# EDGAR Filing Document

**Accession Number:** 0001781755
**File Stem:** 0001781755-25-000109
**Filing Date:** 2025-11
**Character Count:** 241228
**Document Hash:** 7bd1c609aa6a6885c128a6848fa95ce0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001781755-25-000109.hdr.sgml**: 20251104

**ACCESSION NUMBER**: 0001781755-25-000109

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 92

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251104

**DATE AS OF CHANGE**: 20251104

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Baldwin Insurance Group, Inc.
- **CENTRAL INDEX KEY:** 0001781755
- **STANDARD INDUSTRIAL CLASSIFICATION:** INSURANCE AGENTS BROKERS & SERVICES [6411]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 611937225
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39095
- **FILM NUMBER:** 251450149

**BUSINESS ADDRESS:**
- **STREET 1:** 4211 W. BOY SCOUT BLVD.
- **STREET 2:** SUITE 800
- **CITY:** TAMPA
- **STATE:** FL
- **ZIP:** 33607
- **BUSINESS PHONE:** (866) 279-0698

**MAIL ADDRESS:**
- **STREET 1:** 4211 W. BOY SCOUT BLVD.
- **STREET 2:** SUITE 800
- **CITY:** TAMPA
- **STATE:** FL
- **ZIP:** 33607

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BRP Group, Inc.
- **DATE OF NAME CHANGE:** 20190705

?xml version='1.0' encoding='ASCII'? bwin-20250930

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**_________________________________________**

**FORM 10-Q** 

**_________________________________________**

**(Mark One)**

⌧ **Quarterly report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934**

**For the quarterly period ended September 30, 2025** 

**or**

□ **Transition report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934**

**For the transition period from ________ to _________**

**Commission File Number: 001-39095** 

**_________________________________________**

**The Baldwin Insurance Group, Inc.** 

**(Exact name of registrant as specified in its charter)**

**_________________________________________**

---

| | | |
|:---|:---|:---|
| **Delaware** | ![TBG logo std - full color.jpg](bwin-20250930_g1.jpg) | **61-1937225** |
| **(State or other jurisdiction of** | ![TBG logo std - full color.jpg](bwin-20250930_g1.jpg) | **(I.R.S. Employer** |
| **incorporation or organization)** | ![TBG logo std - full color.jpg](bwin-20250930_g1.jpg) | **Identification No.)** |

---

**4211 W. Boy Scout Blvd., Suite 800, Tampa, Florida 33607** 

**(Address of principal executive offices) (Zip Code)**

**(866) 279-0698** 

**(Registrant's telephone number, including area code)**

**Not Applicable**

**(Former Name, former address and former fiscal year, if changed since last report)**

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| **Class A Common Stock, par value $0.01 per share** | **BWIN** | **Nasdaq Global Select Market** |

---

**_________________________________________**

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ⌧ No □

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ⌧ No □

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ⌧ | Accelerated filer | □ |
| Non-accelerated filer | □ | Smaller reporting company | □ |
| | | Emerging growth company | □ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes □ No ⌧

As of October 28, 2025, there were 71,589,503 shares of Class A common stock outstanding and 47,058,818 shares of Class B common stock outstanding.

------

**THE BALDWIN INSURANCE GROUP, INC.**

**INDEX**

---

| | | |
|:---|:---|:---|
| | | **<u>Page</u>** |
| <u>[PART I. FINANCIAL INFORMATION](#icbde7ef1467b499681f0a03eed85e94a_16)</u> | <u>[PART I. FINANCIAL INFORMATION](#icbde7ef1467b499681f0a03eed85e94a_16)</u> |  |
| <u>[ITEM 1.](#icbde7ef1467b499681f0a03eed85e94a_19)</u> | <u>[Financial Statements (Unaudited)](#icbde7ef1467b499681f0a03eed85e94a_19)</u> |  |
|  | <u>[Condensed Consolidated Balance Sheets as of](#icbde7ef1467b499681f0a03eed85e94a_22)[September](#icbde7ef1467b499681f0a03eed85e94a_22)[30, 2025 and December 31, 2024](#icbde7ef1467b499681f0a03eed85e94a_22)</u> | <u>[6](#icbde7ef1467b499681f0a03eed85e94a_22)</u> |
|  | <u>[Condensed Consolidated Statements of Comprehensive Loss for the Three and Nine Months Ended September 30, 2025 and 2024](#icbde7ef1467b499681f0a03eed85e94a_25)</u> | <u>[8](#icbde7ef1467b499681f0a03eed85e94a_25)</u> |
|  | <u>[Condensed Consolidated Statements of Stockholders' Equity and Mezzanine Equity for the Three and Nine Months Ended September 30, 2025 and 2024](#icbde7ef1467b499681f0a03eed85e94a_28)</u> | <u>[9](#icbde7ef1467b499681f0a03eed85e94a_28)</u> |
|  | <u>[Condensed Consolidated Statements of Cash Flows for the Three and](#icbde7ef1467b499681f0a03eed85e94a_31)[Nine](#icbde7ef1467b499681f0a03eed85e94a_31)[Months Ended](#icbde7ef1467b499681f0a03eed85e94a_31)[September](#icbde7ef1467b499681f0a03eed85e94a_31)[30, 2025 and 2024](#icbde7ef1467b499681f0a03eed85e94a_31)</u> | <u>[11](#icbde7ef1467b499681f0a03eed85e94a_31)</u> |
|  | <u>[Notes to Condensed Consolidated Financial Statements](#icbde7ef1467b499681f0a03eed85e94a_34)</u> | <u>[13](#icbde7ef1467b499681f0a03eed85e94a_34)</u> |
| <u>[ITEM 2.](#icbde7ef1467b499681f0a03eed85e94a_88)</u> | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#icbde7ef1467b499681f0a03eed85e94a_88)</u> | <u>[36](#icbde7ef1467b499681f0a03eed85e94a_88)</u> |
| <u>[ITEM 3.](#icbde7ef1467b499681f0a03eed85e94a_133)</u> | <u>[Quantitative and Qualitative Disclosures about Market Risk](#icbde7ef1467b499681f0a03eed85e94a_133)</u> | <u>[55](#icbde7ef1467b499681f0a03eed85e94a_133)</u> |
| <u>[ITEM 4.](#icbde7ef1467b499681f0a03eed85e94a_136)</u> | <u>[Controls and Procedures](#icbde7ef1467b499681f0a03eed85e94a_136)</u> | <u>[55](#icbde7ef1467b499681f0a03eed85e94a_136)</u> |
| <u>[PART II. OTHER INFORMATION](#icbde7ef1467b499681f0a03eed85e94a_139)</u> | <u>[PART II. OTHER INFORMATION](#icbde7ef1467b499681f0a03eed85e94a_139)</u> |  |
| <u>[ITEM 1.](#icbde7ef1467b499681f0a03eed85e94a_142)</u>  | <u>[Legal Proceedings](#icbde7ef1467b499681f0a03eed85e94a_142)</u> | <u>[56](#icbde7ef1467b499681f0a03eed85e94a_142)</u> |
| <u>[ITEM 1A.](#icbde7ef1467b499681f0a03eed85e94a_145)</u> | <u>[Risk Factors](#icbde7ef1467b499681f0a03eed85e94a_145)</u> | <u>[56](#icbde7ef1467b499681f0a03eed85e94a_145)</u> |
| <u>[ITEM 2.](#icbde7ef1467b499681f0a03eed85e94a_148)</u> | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#icbde7ef1467b499681f0a03eed85e94a_148)</u> | <u>[56](#icbde7ef1467b499681f0a03eed85e94a_148)</u> |
| <u>[ITEM 3.](#icbde7ef1467b499681f0a03eed85e94a_151)</u> | <u>[Defaults Upon Senior Securities](#icbde7ef1467b499681f0a03eed85e94a_151)</u> | <u>[56](#icbde7ef1467b499681f0a03eed85e94a_151)</u> |
| <u>[ITEM 4.](#icbde7ef1467b499681f0a03eed85e94a_154)</u> | <u>[Mine Safety Disclosures](#icbde7ef1467b499681f0a03eed85e94a_154)</u> | <u>[56](#icbde7ef1467b499681f0a03eed85e94a_154)</u> |
| <u>[ITEM 5.](#icbde7ef1467b499681f0a03eed85e94a_157)</u> | <u>[Other Information](#icbde7ef1467b499681f0a03eed85e94a_157)</u> | <u>[57](#icbde7ef1467b499681f0a03eed85e94a_157)</u> |
| <u>[ITEM 6.](#icbde7ef1467b499681f0a03eed85e94a_160)</u> | <u>[Exhibits](#icbde7ef1467b499681f0a03eed85e94a_160)</u> | <u>[57](#icbde7ef1467b499681f0a03eed85e94a_160)</u> |
| <u>[SIGNATURES](#icbde7ef1467b499681f0a03eed85e94a_163)</u> | <u>[SIGNATURES](#icbde7ef1467b499681f0a03eed85e94a_163)</u> | <u>[58](#icbde7ef1467b499681f0a03eed85e94a_163)</u> |

---

------

**Note Regarding Forward-Looking Statements**

We have made statements in this report, including matters discussed under Part I, Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations, Part II, Item 1. Legal Proceedings, Part II, Item 1A. Risk Factors and in other sections of this report, that are forward-looking statements. In some cases, you can identify these statements by forward-looking words such as "may," "might," "will," "should," "expects," "plans," "anticipates," "believes," "estimates," "predicts," "potential" or "continue," the negative of these terms and other comparable terminology. These forward-looking statements, which are subject to risks, uncertainties and assumptions about us, may include projections of our future financial performance, our anticipated growth strategies, including, for example, our strategy with respect to future capital allocation and anticipated trends in our business. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements. You should specifically consider the numerous risks outlined under Part I, Item 1A. Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on February 25, 2025.

Although we believe the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of any of these forward-looking statements. We are under no duty to update any of these forward-looking statements after the date of this report to conform our prior statements to actual results or revised expectations, except as required by law.

------

**Commonly Used Defined Terms**

The following terms have the following meanings throughout this Quarterly Report on Form 10-Q unless the context indicates or requires otherwise:

---

| | |
|:---|:---|
| 2019 Stockholders Agreement | Stockholders Agreement between Baldwin and the applicable holders of LLC Units in Baldwin Holdings entered into on October 28, 2019 |
| 2024 Credit Agreement | Amended and Restated Credit Agreement, dated as of May 24, 2024, which is attached as Annex I to the Amendment and Restatement Agreement, dated May 24, 2024, between Baldwin Holdings, as borrower, JPMorgan Chase Bank, N.A., as the Administrative Agent, the Guarantors party thereto and the Lenders party thereto, as amended by Amendment No. 1 to Amended and Restated Credit Agreement, dated as of December 4, 2024, Amendment No. 2 to Amended and Restated Credit Agreement, dated as of January 10, 2025 and Amendment No. 3 to Amended and Restated Credit Agreement, dated as of September 18, 2025 |
| 2024 Credit Facility | The Revolving Facility and 2025 Term Loan Facility established pursuant to the 2024 Credit Agreement, as amended |
| 2024 Stockholders Agreement | Stockholders Agreement between Baldwin and the applicable holders of LLC Units in Baldwin Holdings entered into on October 30, 2024 |
| 2025 Term Loan Facility | Our term loan facility under the 2024 Credit Facility with a principal amount of $1.006 billion, maturing May 24, 2031 |
| adjusted EBITDA | Net income (loss) before interest, taxes, depreciation, amortization, change in fair value of contingent consideration and certain items of income and expense, including share-based compensation expense, transaction-related partnership and integration expenses, severance, and certain non-recurring items, including those related to raising capital |
| Amended LLC Agreement | Third Amended and Restated Limited Liability Company Agreement of Baldwin Holdings, as amended |
| API | Application programming interface |
| book of business | Insurance policies bound by us on behalf of our clients |
| bps | Basis points |
| Baldwin Holdings | The Baldwin Insurance Group Holdings, LLC (formerly Baldwin Risk Partners, LLC), our operating company and a subsidiary of Baldwin |
| Baldwin | The Baldwin Insurance Group, Inc. (formerly BRP Group, Inc.), our parent company, together, unless the context otherwise requires, with its consolidated subsidiaries, including Baldwin Holdings and its consolidated subsidiaries and affiliates |
| Capacity Solutions | A division of our Underwriting, Capacity & Technology Solutions operating group that includes our reinsurance brokerage business, Juniper Re, our reinsurance MGA business, MultiStrat, and our captive management business |
| Captive | The initial series, MSI Multifamily Series Protected Cell, together with the Core, TBG Assurance Company, LLC |
| clients | Our insureds |
| colleagues | Our employees |
| core commissions and fees | Revenue generated from commissions, consulting and service fees, policy fees and installment payments, as well as earned premiums from assumed insurance contracts, collectively |
| Exchange Act | Securities Exchange Act of 1934, as amended |
| GAAP | Accounting principles generally accepted in the United States of America |
| insurance company partners | Insurance companies with which we have a contractual relationship |
| LLC Units | Membership interests of Baldwin Holdings |
| MGA | Managing General Agent |
| MSI | Our MGA platform |
| operating groups | Our reportable segments |
| partners | Companies that we have acquired, or in the case of asset acquisitions, the producers |

---

------

---

| | |
|:---|:---|
| partnerships | Strategic acquisitions made by the Company |
| Pre-IPO LLC Members | Trevor Baldwin, our Chief Executive Officer; Lowry Baldwin, our Chairman; BIGH, LLC, an entity controlled by Lowry Baldwin; Elizabeth Krystyn, one of our founders; Laura Sherman, one of our founders; Daniel Galbraith, President, The Baldwin Group and CEO, Retail Brokerage Operations; Brad Hale, our Chief Financial Officer; and The Villages Invesco, LLC; and certain other historical equity holders including equity holders in companies that we have acquired or producers |
| reinsurance company partners | Reinsurance companies with which we have a contractual relationship |
| Revolving Facility | Our revolving credit facility under the 2024 Credit Facility with commitments in an aggregate principal amount of $600 million, maturing May 24, 2029 |
| risk advisors | Our producers |
| SEC | U.S. Securities and Exchange Commission |
| Securities Act | Securities Act of 1933, as amended |
| Senior Secured Notes | 7.125% senior secured notes with an aggregate principal amount of $600 million due May 15, 2031 |
| SOFR | Secured Overnight Financing Rate |
| Tax Receivable Agreement | Tax Receivable Agreement between Baldwin and certain holders of LLC Units in Baldwin Holdings entered into on October 28, 2019 |
| Westwood | Westwood Insurance Agency, a 2022 partner |
| Wholesale Business | Our specialty wholesale broker business, which was sold on March 1, 2024 |

---

------

**PART I. FINANCIAL INFORMATION**

**ITEM 1. FINANCIAL STATEMENTS**

**THE BALDWIN INSURANCE GROUP, INC.**

**Condensed Consolidated Balance Sheets**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
| **(in thousands, except share and per share data)** | **September 30, 2025** | **December 31, 2024** |
| **Assets** | | |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $89723 | $90045 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fiduciary cash | 236221 | 222724 |
| &nbsp;&nbsp;&nbsp;&nbsp;Assumed premiums, commissions and fees receivable, net | 346466 | 283553 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fiduciary receivables | 416083 | 418543 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 17702 | 11625 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 1106195 | 1026490 |
| Property and equipment, net | 21193 | 21972 |
| Right-of-use assets | 64266 | 72367 |
| Other assets | 68945 | 48041 |
| Intangible assets, net | 1016687 | 953492 |
| Goodwill | 1516488 | 1412369 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total assets | $3793774 | $3534731 |
| **Liabilities, Mezzanine Equity and Stockholders**' **Equity** |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Fiduciary liabilities | $652304 | $641267 |
| &nbsp;&nbsp;&nbsp;&nbsp;Commissions payable | 68682 | 73126 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses and other current liabilities | 221665 | 160631 |
| &nbsp;&nbsp;&nbsp;&nbsp;Related party notes payable |  | 5635 |
| &nbsp;&nbsp;&nbsp;&nbsp;Colleague earnout incentives |  | 32826 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current portion of contingent earnout liabilities | 17062 | 142949 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 959713 | 1056434 |
| Revolving line of credit | 66000 |  |
| Long-term debt, less current portion | 1567563 | 1398054 |
| Contingent earnout liabilities, less current portion | 11330 | 2610 |
| Operating lease liabilities, less current portion | 60917 | 68775 |
| Other liabilities | 61 | 61 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 2665584 | 2525934 |
| Commitments and contingencies (Note 16) |  |  |
| Mezzanine equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Redeemable noncontrolling interest | 510 | 453 |
| Stockholders' equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Class A common stock, par value $0.01 per share, 300,000,000 shares authorized; 71,416,940 and 67,979,419 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively | 714 | 680 |
| &nbsp;&nbsp;&nbsp;&nbsp;Class B common stock, par value $0.0001 per share, 100,000,000 shares authorized; 47,168,818 and 49,552,686 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively | 5 | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 837293 | 793954 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated deficit | (219375) | (211423) |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive income | 1050 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity attributable to Baldwin | 619687 | 583216 |
| &nbsp;&nbsp;&nbsp;&nbsp;Noncontrolling interest | 507993 | 425128 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity | 1127680 | 1008344 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities, mezzanine equity and stockholders' equity | $3793774 | $3534731 |

---

See accompanying Notes to Condensed Consolidated Financial Statements.

------

**THE BALDWIN INSURANCE GROUP, INC.**

**Condensed Consolidated Balance Sheets (Continued)**

**(Unaudited)**

The following table presents the assets and liabilities of the Company's consolidated variable interest entities, which are included on the consolidated balance sheets above. The assets in the table below include those assets that can only be used to settle obligations of the consolidated variable interest entities.

---

| | | |
|:---|:---|:---|
| **(in thousands)** | **September 30, 2025** | **December 31, 2024** |
| **Assets of Consolidated Variable Interest Entities That Can Only be Used to Settle the Obligations of Consolidated Variable Interest Entities:** | | |
| Cash and cash equivalents | $4317 | $1032 |
| Assumed premiums, commissions and fees receivable, net | 1611 | 491 |
| Prepaid expenses and other current assets | 76 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 6004 | 1523 |
| Right-of-use assets | 29 | 53 |
| Other assets | 5 | 7 |
| Intangible assets, net | 67972 |  |
| Goodwill | 50834 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total assets | $124844 | $1583 |
| **Liabilities of Consolidated Variable Interest Entities for Which Creditors Do Not Have Recourse to the Company:** |  |  |
| Commissions payable | $76 | $62 |
| Accrued expenses and other current liabilities | 5271 | 63 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 5347 | 125 |
| Operating lease liabilities, less current portion |  | 21 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | $5347 | $146 |

---

See accompanying Notes to Condensed Consolidated Financial Statements.

------

**THE BALDWIN INSURANCE GROUP, INC.**

**Condensed Consolidated Statements of Comprehensive Loss**

**(Unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For the Three Months<br> Ended September 30,** | **For the Three Months<br> Ended September 30,** | **For the Nine Months<br> Ended September 30,** | **For the Nine Months<br> Ended September 30,** |
| **(in thousands, except share and per share data)** | **2025** | **2024** | **2025** | **2024** |
| Revenues: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Commissions and fees | $362317 | $335210 | $1149097 | $1050409 |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment income | 3072 | 3728 | 8508 | 8736 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | 365389 | 338938 | 1157605 | 1059145 |
| Operating expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Colleague compensation and benefits | 193031 | 172645 | 586522 | 549359 |
| &nbsp;&nbsp;&nbsp;&nbsp;Outside commissions | 79111 | 74544 | 218520 | 204237 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other operating expenses | 56008 | 48839 | 170146 | 141198 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization expense | 30394 | 26899 | 82286 | 76334 |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of contingent consideration | 1980 | (952) | 8084 | 17276 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation expense | 1649 | 1557 | 4874 | 4619 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 362173 | 323532 | 1070432 | 993023 |
| Operating income | 3216 | 15406 | 87173 | 66122 |
| Other income (expense): |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense, net | (31132) | (31329) | (92428) | (94203) |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on divestitures |  | 1809 | 290 | 38953 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on extinguishment and modification of debt | (3290) | (389) | (5684) | (15068) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income, net | 860 | 28 | 745 | 105 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other expense, net | (33562) | (29881) | (97077) | (70213) |
| Loss before income taxes and share of net earnings of equity method investee | (30346) | (14475) | (9904) | (4091) |
| &nbsp;&nbsp;&nbsp;&nbsp;Share of net earnings of equity method investee | 109 |  | 109 |  |
| Loss before income taxes | (30237) | (14475) | (9795) | (4091) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax expense |  |  | 685 | 2151 |
| Net loss | (30237) | (14475) | (10480) | (6242) |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: net loss attributable to noncontrolling interests | (11510) | (6098) | (2528) | (1886) |
| Net loss attributable to Baldwin | $(18727) | $(8377) | $(7952) | $(4356) |
| Net loss | $(30237) | $(14475) | $(10480) | $(6242) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income | 1050 |  | 1050 |  |
| Comprehensive loss | (29187) | (14475) | (9430) | (6242) |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Comprehensive loss attributable to noncontrolling interests | (11510) | (6098) | (2528) | (1886) |
| Comprehensive loss attributable to Baldwin | $(17677) | $(8377) | $(6902) | $(4356) |
| Basic and diluted loss per share | $(0.27) | $(0.13) | $(0.12) | $(0.07) |
| Weighted-average shares of Class A common stock outstanding - basic and diluted | 68604951 | 64011515 | 67571899 | 63001125 |

---

See accompanying Notes to Condensed Consolidated Financial Statements.

------

**THE BALDWIN INSURANCE GROUP, INC.**

**Condensed Consolidated Statements of Stockholders' Equity and Mezzanine Equity**

 **(Unaudited)**

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** |
| | **Stockholders**' **Equity** | **Stockholders**' **Equity** | **Stockholders**' **Equity** | **Stockholders**' **Equity** | **Stockholders**' **Equity** | **Stockholders**' **Equity** | **Stockholders**' **Equity** | **Stockholders**' **Equity** | **Stockholders**' **Equity** | **Mezzanine Equity** |
| | **Class A Common Stock** | **Class A Common Stock** | **Class B Common Stock** | **Class B Common Stock** | **Additional Paid-in Capital** | **Accumulated Deficit** | **Accumu-<br>lated<br>Other<br>Compre-<br>hensive<br>Income** | **Non-controlling Interest** | **Total** | **Redeemable Non-controlling Interest** |
| **(in thousands, except share data)** | **Shares** | **Amount** | **Shares** | **Amount** | **Additional Paid-in Capital** | **Accumulated Deficit** | **Accumu-<br>lated<br>Other<br>Compre-<br>hensive<br>Income** | **Non-controlling Interest** | **Total** | **Redeemable Non-controlling Interest** |
| Balance at June 30, 2025 | 71278683 | $713 | 47358729 | $5 | $830735 | $(200648) | $— | $419119 | $1049924 | $445 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) |  |  |  |  |  | (18727) |  | (11575) | (30302) | 65 |
| &nbsp;&nbsp;&nbsp;&nbsp;Noncontrolling interest acquired in business combinations |  |  |  |  |  |  |  | 97920 | 97920 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation, net of forfeitures | (51654) | (1) |  |  | 5468 |  |  | 3621 | 9088 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Redemption of Class B common stock | 189911 | 2 | (189911) |  | 1090 |  |  | (1092) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income |  |  |  |  |  |  | 1050 |  | 1050 |  |
| Balance at September 30, 2025 | 71416940 | $714 | 47168818 | $5 | $837293 | $(219375) | $1050 | $507993 | $1127680 | $510 |

---

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **For the Nine Months Ended September 30, 2025** | **For the Nine Months Ended September 30, 2025** | **For the Nine Months Ended September 30, 2025** | **For the Nine Months Ended September 30, 2025** | **For the Nine Months Ended September 30, 2025** | **For the Nine Months Ended September 30, 2025** | **For the Nine Months Ended September 30, 2025** | **For the Nine Months Ended September 30, 2025** | **For the Nine Months Ended September 30, 2025** | **For the Nine Months Ended September 30, 2025** | **For the Nine Months Ended September 30, 2025** |
| | **Stockholders**' **Equity** | **Stockholders**' **Equity** | **Stockholders**' **Equity** | **Stockholders**' **Equity** | **Stockholders**' **Equity** | **Stockholders**' **Equity** | **Stockholders**' **Equity** | **Stockholders**' **Equity** | **Stockholders**' **Equity** | **Mezzanine Equity** |
| | **Class A Common Stock** | **Class A Common Stock** | **Class B Common Stock** | **Class B Common Stock** | **Additional Paid-in Capital** | **Accumulated Deficit** | **Accumu-<br>llated<br>Other<br>Compre-<br>hensive<br>Income** | **Non-controlling Interest** | **Total** | **Redeemable Non-controlling Interest** |
| **(in thousands, except share data)** | **Shares** | **Amount** | **Shares** | **Amount** | **Additional Paid-in Capital** | **Accumulated Deficit** | **Accumu-<br>llated<br>Other<br>Compre-<br>hensive<br>Income** | **Non-controlling Interest** | **Total** | **Redeemable Non-controlling Interest** |
| Balance at December 31, 2024 | 67979419 | $680 | 49552686 | $5 | $793954 | $(211423) | $— | $425128 | $1008344 | $453 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) |  |  |  |  |  | (7952) |  | (2750) | (10702) | 222 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity issued in business combinations | 23202 |  |  |  | 515 |  |  | 348 | 863 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Noncontrolling interest acquired in business combinations |  |  |  |  |  |  |  | 97920 | 97920 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation, net of forfeitures | 1030451 | 10 |  |  | 18189 |  |  | 12351 | 30550 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Redemption of Class B common stock | 2383868 | 24 | (2383868) |  | 24635 |  |  | (24659) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributions to variable interest entities |  |  |  |  |  |  |  | (345) | (345) | (165) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income |  |  |  |  |  |  | 1050 |  | 1050 |  |
| Balance at September 30, 2025 | 71416940 | $714 | 47168818 | $5 | $837293 | $(219375) | $1050 | $507993 | $1127680 | $510 |

---

See accompanying Notes to Condensed Consolidated Financial Statements.

------

**THE BALDWIN INSURANCE GROUP, INC.**

**Condensed Consolidated Statements of Stockholders' Equity and Mezzanine Equity (Continued)**

**(Unaudited)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** |
| | **Stockholders' Equity** | **Stockholders' Equity** | **Stockholders' Equity** | **Stockholders' Equity** | **Stockholders' Equity** | **Stockholders' Equity** | **Stockholders' Equity** | **Stockholders' Equity** | **Mezzanine Equity** |
| | **Class A Common Stock** | **Class A Common Stock** | **Class B Common Stock** | **Class B Common Stock** | **Additional Paid-in Capital** | **Accumulated Deficit** | **Non-controlling Interest** | **Total** | **Redeemable Non-controlling Interest** |
| **(in thousands, except share data)** | **Shares** | **Amount** | **Shares** | **Amount** | **Additional Paid-in Capital** | **Accumulated Deficit** | **Non-controlling Interest** | **Total** | **Redeemable Non-controlling Interest** |
| Balance at June 30, 2024 | 66544590 | $665 | 50943644 | $5 | $773109 | $(182884) | $452364 | $1043259 | $286 |
| &nbsp;&nbsp;&nbsp;Net income (loss) |  |  |  |  |  | (8377) | (6187) | (14564) | 89 |
| &nbsp;&nbsp;&nbsp;Share-based compensation, net of forfeitures | 61676 | 1 |  |  | 4323 |  | 3215 | 7539 |  |
| &nbsp;&nbsp;&nbsp;Redemption of Class B common stock | 930081 | 9 | (930081) |  | 8499 |  | (8508) |  |  |
| Balance at September 30, 2024 | 67536347 | $675 | 50013563 | $5 | $785931 | $(191261) | $440884 | $1036234 | $375 |

---

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **For the Nine Months Ended September 30, 2024** | **For the Nine Months Ended September 30, 2024** | **For the Nine Months Ended September 30, 2024** | **For the Nine Months Ended September 30, 2024** | **For the Nine Months Ended September 30, 2024** | **For the Nine Months Ended September 30, 2024** | **For the Nine Months Ended September 30, 2024** | **For the Nine Months Ended September 30, 2024** | **For the Nine Months Ended September 30, 2024** | **For the Nine Months Ended September 30, 2024** |
| | **Stockholders' Equity** | **Stockholders' Equity** | **Stockholders' Equity** | **Stockholders' Equity** | **Stockholders' Equity** | **Stockholders' Equity** | **Stockholders' Equity** | **Stockholders' Equity** | **Mezzanine Equity** |
| | **Class A Common Stock** | **Class A Common Stock** | **Class B Common Stock** | **Class B Common Stock** | **Additional Paid-in Capital** | **Accumulated Deficit** | **Non-controlling Interest** | **Total** | **Redeemable Non-controlling Interest** |
| **(in thousands, except share data)** | **Shares** | **Amount** | **Shares** | **Amount** | **Additional Paid-in Capital** | **Accumulated Deficit** | **Non-controlling Interest** | **Total** | **Redeemable Non-controlling Interest** |
| Balance at December 31, 2023 | 64133950 | $641 | 52422494 | $5 | $746671 | $(186905) | $458076 | $1018488 | $394 |
| &nbsp;&nbsp;&nbsp;Net income (loss) |  |  |  |  |  | (4356) | (2131) | (6487) | 245 |
| &nbsp;&nbsp;&nbsp;Share-based compensation, net of forfeitures | 993466 | 10 |  |  | 19878 |  | 15421 | 35309 |  |
| &nbsp;&nbsp;&nbsp;Redemption of Class B common stock | 2408931 | 24 | (2408931) |  | 19382 |  | (19406) |  |  |
| &nbsp;&nbsp;&nbsp;Tax distributions to Baldwin Holdings LLC members |  |  |  |  |  |  | (11076) | (11076) |  |
| &nbsp;&nbsp;&nbsp;Distributions to variable interest entities |  |  |  |  |  |  |  |  | (264) |
| Balance at September 30, 2024 | 67536347 | $675 | 50013563 | $5 | $785931 | $(191261) | $440884 | $1036234 | $375 |

---

See accompanying Notes to Condensed Consolidated Financial Statements.

------

**THE BALDWIN INSURANCE GROUP, INC.**

**Condensed Consolidated Statements of Cash Flows**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
| | **For the Nine Months<br> Ended September 30,** | **For the Nine Months<br> Ended September 30,** |
| **(in thousands)** | **2025** | **2024** |
| Cash flows from operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss | $(10480) | $(6242) |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net loss to net cash provided by (used in) operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 87160 | 80953 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of contingent consideration | 8084 | 17276 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation expense | 51772 | 46764 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment of contingent earnout consideration in excess of purchase price accrual | (85090) | (21145) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on divestitures | (290) | (38953) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of deferred financing costs | 4266 | 4419 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss on extinguishment of debt | 26 | 1034 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other operating activity | (831) | 590 |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Assumed premiums, commissions and fees receivable, net | (49392) | (29792) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | (7555) | (7980) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Right-of-use assets | 12047 | 12562 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable, accrued expenses and other current liabilities | (4898) | 5895 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Colleague earnout incentives | (32813) | (439) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities | (11693) | (11188) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by (used in) operating activities | (39687) | 53754 |
| Cash flows from investing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures | (29174) | (28897) |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash consideration paid for business combinations, net of cash received | (85511) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from divestitures, net of cash transferred | 1901 | 56977 |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments in and loans for business ventures | (16333) | (3703) |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash consideration paid for asset acquisitions | (460) | (268) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from repayment of related party loans |  | 1500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by (used in) investing activities | (129577) | 25609 |
| Cash flows from financing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in fiduciary receivables and liabilities, net | 13497 | 31954 |
| &nbsp;&nbsp;&nbsp;&nbsp;Payment of contingent earnout consideration up to amount of purchase price accrual | (64256) | (64698) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from revolving line of credit | 214000 | 95000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Payments on revolving line of credit | (148000) | (436000) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from refinancing of long-term debt | 1941921 | 1440000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Payments relating to extinguishment and modification of long-term debt | (1766921) | (996177) |
| &nbsp;&nbsp;&nbsp;&nbsp;Payments on long-term debt | (7194) | (4661) |
| &nbsp;&nbsp;&nbsp;&nbsp;Payments of deferred financing costs | (92) | (17988) |
| &nbsp;&nbsp;&nbsp;&nbsp;Tax distributions to Baldwin Holdings LLC members |  | (11076) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other financing activity | (516) | 2036 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by financing activities | 182439 | 38390 |
| Net increase in cash and cash equivalents and fiduciary cash | 13175 | 117753 |
| Cash and cash equivalents and fiduciary cash at beginning of period | 312769 | 226963 |
| Cash and cash equivalents and fiduciary cash at end of period | $325944 | $344716 |

---

------

**THE BALDWIN INSURANCE GROUP, INC.**

**Condensed Consolidated Statements of Cash Flows (Continued)**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
| | **For the Nine Months<br> Ended September 30,** | **For the Nine Months<br> Ended September 30,** |
| **(in thousands)** | **2025** | **2024** |
| Supplemental schedule of cash flow information: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash paid during the period for interest | $76612 | $73417 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash paid during the period for income taxes | 1525 | 2717 |
| Disclosure of non-cash investing and financing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Noncontrolling interest acquired in business combinations | $97920 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred payment obligations recognized in business combinations | 32346 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Contingent earnout liabilities recognized in business combinations | 18447 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Right-of-use assets obtained in exchange for operating lease liabilities | 2254 | 2111 |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures incurred but not yet paid | 2213 | 1821 |
| &nbsp;&nbsp;&nbsp;&nbsp;Right-of-use assets increased (decreased) through lease modifications and reassessments | 2100 | (99) |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity issued in business combinations | 863 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Conversion of contingent earnout liability to related party notes payable |  | 5636 |

---

See accompanying Notes to Condensed Consolidated Financial Statements.

------

**THE BALDWIN INSURANCE GROUP, INC.**

**Notes to Condensed Consolidated Financial Statements**

**(Unaudited)**

**1. Business and Basis of Presentation**

The Baldwin Insurance Group, Inc. was incorporated in the state of Delaware on July 1, 2019 as BRP Group, Inc. and, on May 2, 2024, was renamed The Baldwin Insurance Group, Inc.

The Baldwin Insurance Group, Inc. is a holding company and sole managing member of The Baldwin Insurance Group Holdings, LLC (formerly Baldwin Risk Partners, LLC) ("Baldwin Holdings") and its sole material asset is its ownership interest in Baldwin Holdings, through which all of its business has been and is conducted. In these condensed consolidated financial statements, unless the context otherwise requires, the words "Baldwin," and the "Company" refer to The Baldwin Insurance Group, Inc., together with its consolidated subsidiaries, including Baldwin Holdings and its consolidated subsidiaries and affiliates.

Baldwin is a diversified insurance agency and services organization that markets and sells insurance products and services to its clients throughout the U.S. A significant portion of the Company's business is concentrated in the Southeastern U.S., with several other regional concentrations. Baldwin and its subsidiaries operate through three reportable segments ("operating groups"), Insurance Advisory Solutions, Underwriting, Capacity & Technology Solutions and Mainstreet Insurance Solutions, which are discussed in more detail in Note 17.

**Principles of Consolidation**

The consolidated financial statements include the accounts of Baldwin and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.

As the sole manager of Baldwin Holdings, Baldwin operates and controls all the business and affairs of Baldwin Holdings, and has the sole voting interest in, and controls the management of, Baldwin Holdings. Accordingly, Baldwin consolidates Baldwin Holdings in its consolidated financial statements, resulting in a noncontrolling interest related to the membership interests of Baldwin Holdings (the "LLC Units") held by Baldwin Holdings' members in the Company's consolidated financial statements.

The Company has prepared these condensed consolidated financial statements in accordance with Accounting Standards Codification ("ASC") Topic 810, *Consolidation* ("Topic 810"). Topic 810 requires that if an enterprise is the primary beneficiary of a variable interest entity, the assets, liabilities, and results of operations of the variable interest entity should be included in the consolidated financial statements of the enterprise. The Company has recognized certain entities as variable interest entities, of which the Company is the primary beneficiary, and has included the accounts of these entities in the consolidated financial statements. Refer to Note 4 for additional information regarding the Company's variable interest entities.

Topic 810 also requires that the equity of a noncontrolling interest shall be reported on the condensed consolidated balance sheets within total equity of the Company. Certain redeemable noncontrolling interests are reported on the condensed consolidated balance sheets as mezzanine equity. Topic 810 also requires revenues, expenses, gains, losses, net income or loss, and other comprehensive income or loss to be reported in the consolidated financial statements at consolidated amounts, which include amounts attributable to the owners of the parent and the noncontrolling interests.

**Unaudited Interim Financial Reporting**

The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and applicable rules and regulations of the Securities and Exchange Commission ("SEC") regarding interim financial reporting. Accordingly, they do not include all the information and related notes required by GAAP for complete consolidated financial statements. In the opinion of management, all adjustments, consisting of recurring accruals, considered necessary for fair presentation of the financial statements have been included. The accompanying consolidated balance sheet for the year ended December 31, 2024 was derived from audited financial statements, but does not include all disclosures required by GAAP. Accordingly, these unaudited interim condensed consolidated financial statements should be read in conjunction with the Company's audited consolidated financial statements and the notes thereto for the year ended December 31, 2024 included in the Company's Annual Report on Form 10-K filed with the SEC on February 25, 2025.

------

**Use of Estimates**

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from these estimates. Significant estimates underlying the accompanying condensed consolidated financial statements include the application of guidance for revenue recognition; the impairment of intangible assets and goodwill; the valuation of acquired relationships and contingent consideration; and the valuation allowance for deferred tax assets.

**Recently Issued Accounting Standards**

In November 2024, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2024-03, *Income Statement*—*Reporting Comprehensive Income*—*Expense Disaggregation Disclosures (Subtopic 220-40)*—*Disaggregation of Income Statement Expenses* ("ASU 2024-03") to improve the disclosures about a public business entity's expenses and supply more detailed information about the types of expenses in commonly presented expense captions. These expenses include purchases of inventory, employee compensation, depreciation, amortization, and depletion in commonly presented expense captions such as cost of sales, selling, general and administrative expense, and research and development expense. This guidance is effective for annual reporting periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027. The Company expects the adoption of this standard to expand its expense disclosures, but otherwise have no impact on the interim or annual consolidated financial statements.

In May 2025, the FASB issued ASU No. 2025-03, *Business Combinations (Topic 805) and Consolidation (Topic 810): Determining the Accounting Acquirer in the Acquisition of a Variable Interest Entity* ("ASU 2025-03"). ASU 2025-03 amends the guidance for identifying the accounting acquirer in a business combination effected primarily by exchanging equity interests when the legal acquiree is a variable interest entity ("VIE") that meets the definition of a business. Under the new guidance, entities must consider the factors in ASC 805-10-55-12 through 55-15—such as relative voting rights, composition of the governing body and management, and size of the combining entities—regardless of whether the legal acquiree is a VIE. This change is intended to improve consistency and comparability in financial reporting for economically similar transactions. This guidance is effective for annual reporting periods beginning after December 15, 2026, and interim periods within those annual periods, with early adoption permitted. The Company will apply the amendments prospectively to business combinations occurring after the initial application. The Company expects the adoption of this standard to change how it evaluates the accounting acquirer in future business combinations involving a VIE, but otherwise have no impact on the consolidated financial statements.

In September 2025, the FASB issued ASU No. 2025-06, *Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software* ("ASU 2025-06"). ASU 2025-06 updates the accounting framework for internal-use software development costs to better reflect modern development practices, including agile methodologies. Key changes include replacing the traditional project stage model with a capitalization threshold based on management's authorization and commitment to fund the project, along with a requirement that completion of the project be probable. ASU 2025-06 also supersedes guidance on website development costs. This guidance is effective for fiscal years beginning after December 15, 2027 and interim periods within those fiscal years. The Company is currently evaluating the impact this standard will have on the interim or annual consolidated financial statements.

**Recently Adopted Accounting Standards**

In December 2023, the FASB issued ASU No. 2023-09, *Income Taxes (Topic 740)*—*Improvements to Income Tax Disclosures* ("ASU 2023-09") to enhance the transparency and usefulness of income tax disclosures. ASU 2023-09 requires disclosure of specific categories and disaggregation of information in the rate reconciliation table using both percentages and reporting currency amounts. ASU 2023-09 also requires disclosure of disaggregated information related to income taxes paid, income or loss from continuing operations before income tax expense or benefit, and income tax expense or benefit from continuing operations. The requirements of ASU 2023-09 became effective for the Company January 1, 2025, at which time it was adopted. However, the Company is not required to provide income tax disclosures on a quarterly basis; therefore, the new disclosures will be included in its Annual Report on Form 10-K for the year ending December 31, 2025 as required.

------

**Changes in Presentation**

Certain prior year amounts have been reclassified to conform to current year presentation, including the addition of a new operating expense classification, outside commissions, to provide more detailed information about the Company's expenses. With the exception of the change in presentation for fiduciary assets and liabilities as discussed below, these reclassifications had no impact on the Company's previously reported consolidated financial position, results of operations or cash flows.

***Change in Presentation for Fiduciary Assets and Liabilities***

Beginning January 1, 2025, the Company is presenting assets and liabilities that arise from activities in which the Company engages as an intermediary, where we collect premiums from insureds to remit to insurance companies, as fiduciary assets and fiduciary liabilities on the condensed consolidated balance sheets. Premiums receivable are no longer presented in the same caption with uncollected commissions and fees, but rather represented in a separate caption as fiduciary receivables. Premiums payable to insurance companies are now presented as fiduciary liabilities. In addition, restricted cash is now reflected as fiduciary cash along with non-restricted fiduciary cash balances previously reported within cash and cash equivalents. Fiduciary cash represents funds in the Company's possession that have been collected from customers to be remitted to insurance companies.

The net change in fiduciary cash is represented by the net change in fiduciary receivables and liabilities and is presented as cash flows from financing activities in the condensed consolidated statements of cash flows. Previously, the net change in cash balances held to remit to insurance carriers was presented as cash flows from operating activities. All prior period amounts and related disclosures included in these financial statements have been recast to conform to the current basis of presentation.

The table below presents the changes in the relevant balance sheet captions at December 31, 2024 from amounts as previously reported to the revised presentation.

---

| | | | |
|:---|:---|:---|:---|
| | **At December 31, 2024** | **At December 31, 2024** | **At December 31, 2024** |
| **(in thousands)** | **As Previously Reported** | **Change in Presentation** | **As Revised** |
| Cash and cash equivalents | $148120 | $(58075) | $90045 |
| Restricted cash | 164649 | (164649) |  |
| Fiduciary cash |  | 222724 | 222724 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $312769 | $— | $312769 |
| Premiums, commissions and fees receivables, net | $702096 | $(702096) | $— |
| Assumed premiums, commissions and fees receivable, net |  | 283553 | 283553 |
| Fiduciary receivables |  | 418543 | 418543 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $702096 | $— | $702096 |
| Premiums payable to insurance companies | $641267 | $(641267) | $— |
| Fiduciary liabilities |  | 641267 | 641267 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $641267 | $— | $641267 |

---

------

The table below presents the changes in the relevant statement of cash flow captions for the nine months ended September 30, 2024 from amounts as previously reported to the revised presentation.

---

| | | | |
|:---|:---|:---|:---|
| | **For the Nine Months Ended September 30, 2024** | **For the Nine Months Ended September 30, 2024** | **For the Nine Months Ended September 30, 2024** |
| **(in thousands)** | **As Previously Reported** | **Change in Presentation** | **As Revised** |
| Cash flows from operating activities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Premiums, commissions and fees receivable, net | $(27777) | $27777 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Assumed premiums, commissions and fees receivable, net |  | (29792) | (29792) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable, accrued expenses and other current liabilities | 35395 | (29500) | 5895 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Colleague earnout incentives<sup>(1)</sup> |  | (439) | (439) |
| Cash flows from financing activities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in fiduciary assets and liabilities, net |  | 31954 | 31954 |
| Total represented changes in cash flows | $7618 | $— | $7618 |

---

__________

(1)&nbsp;&nbsp;&nbsp;&nbsp;Beginning December 31, 2024, colleague earnout incentives were presented separately on the face of the consolidated balance sheets unrelated to the change in presentation for fiduciary assets and liabilities. Changes in colleague earnout incentives are included in this table only to present the effect of this reclassification on the changes in accounts payable, accrued expenses and other current liabilities.

**2. Significant Accounting Policies**

**Revenue Recognition**

The Company generally recognizes revenue in accordance with ASC Topic 606, *Revenue from Contracts with Customers* ("Topic 606").

The Company earns commission revenue by providing insurance placement services to insureds or insurance companies ("clients") under direct bill and agency bill arrangements with insurance company partners or reinsurance company partners for private risk management, commercial risk management, employee benefits and Medicare insurance types. Commission revenues are usually a percentage of the premium paid by clients and generally depend upon the type of insurance, the insurance company partner or reinsurance company partner, and the nature of the services provided. In some cases, the Company shares commissions with other agents or brokers who have acted jointly with the Company in a transaction. The Company controls the fulfillment of the performance obligation and its relationship with its insurance company partners, reinsurance company partners, and the outside agents. Commissions shared with downstream agents or brokers are recorded in outside commissions in the condensed consolidated statements of comprehensive loss.

Commission revenue is recorded net of allowances for estimated policy cancellations, which are determined based on an evaluation of historical and current cancellation data.

Commissions for brokerage services may be invoiced near the effective date of the underlying policy or over the term of the arrangement in installments during the policy period. However, regardless of the payment terms, commissions are recognized at a point in time upon the effective date of bound insurance coverage, as no performance obligation exists after coverage is bound.

The Company earns service fee revenue for providing insurance placement services to clients for a negotiated fee, and consulting revenue is earned by providing specialty insurance consulting and other advisory services. Service fee and consulting revenues from certain agreements are recognized over time depending on when the services within the contract are satisfied and when the Company has transferred control of the related services to the customer.

------

Profit-sharing commissions represent bonus-type revenue that is earned by the Company as a sales incentive provided by certain insurance company partners and reinsurance company partners. The Company receives profit-sharing commissions based primarily on underwriting results, but may also contain considerations for volume, growth, loss performance or retention. Profit-sharing commissions associated with relatively predictable measures are estimated and recognized over time. The profit-sharing commissions are recorded as the underlying policies that contribute to the achievement of the metric are placed with any adjustments recognized when payments are received or as additional information that affects the estimate becomes available. Profit-sharing commissions associated with loss performance are uncertain, and therefore, are subject to significant reversal as loss data remains subject to material change. Management estimates profit-sharing commissions using historical outcomes and known trends impacting premium volume or loss ratios, subject to a constraint. The constraint is relieved when management estimates the revenue is not subject to significant reversal, which often coincides with the earlier of written notice from the insurance company partner that the target has been achieved, or cash collection. Year-end and quarter-end amounts incorporate estimates subject to a constraint or where applicable, are based on confirmation from insurance company partners after calculation of premium volume or loss ratios that are impacted by catastrophic losses.

The Company earns policy fee revenue for acting in its capacity as a managing general agent ("MGA") on behalf of the insurance company partner and fulfilling certain services, including delivery of policy documents, processing payments and other administrative functions during the term of the insurance policy. Policy fee revenue is deferred and recognized over the life of the policy. These deferred amounts are recognized as contract liabilities, which are included as a component of accrued expenses and other current liabilities on the consolidated balance sheets. The Company earns installment fee revenue for payment processing services performed on behalf of the insurance company partner related to policy premiums paid on an installment basis. The Company recognizes installment fee revenue in the period the services are performed.

The Company pays an incremental amount of compensation in the form of producer commissions on new business. These incremental costs are capitalized as deferred commission expense and amortized over five years, which represents management's estimate of the average benefit period for new business. The Company has concluded that this period is consistent with the transfer to the client of the services to which the asset relates.

Due to the relatively short time period between the information gathering phase and binding insurance coverage, the Company has determined that costs to fulfill contracts are not significant. Therefore, costs to fulfill a contract are expensed as incurred.

The Company recognizes revenue for the Captive business (as defined further below) in accordance with ASC Topic 944, *Insurance*, in the form of assumed premium earned. Assumed premium earned is recognized ratably over the associated policy periods.

The Company also earns investment income, which primarily consists of interest earnings on available cash invested in treasury money market funds. The Company recognizes investment income in the period the revenue is earned.

**Captive Insurance Operations**

The Company's Underwriting, Capacity & Technology Solutions operating group includes TBG Assurance Company, LLC, a wholly-owned protected cell captive insurance company ("PCC") domiciled in Tennessee, which was established to allow Baldwin to further participate in the underwriting results of a small portion of its MGA programs. The PCC allows for the creation of multiple independent cells (series) within a single legal entity, TBG Assurance Company, LLC (the "Core").

Effective January 1, 2025, the initial series, MSI Multifamily Series Protected Cell (the "MSI Cell," and collectively with the Core, the "Captive"), was licensed and participates as a quota share reinsurer on two of MSI's multifamily programs, renters and master tenant legal liability, for the purpose of further participating in the programs' underwriting results. The reinsurance quota share contracts feature an adjustment to assumed premium based on the loss ratio performance of the business ceded.

Assumed premiums are recognized as income over the coverage period of the related policies. Unearned premiums represent the portion of premiums written that relate to the unexpired terms of the policies in force and are determined on a pro rata basis. Assumed premium earned is recorded to commissions and fees in the condensed consolidated statements of comprehensive loss. Assumed premiums receivable are included as a component of assumed premiums, commissions and fees receivable, net on the condensed consolidated balance sheets. Unearned premiums are included as a component of accrued expenses and other current liabilities on the condensed consolidated balance sheets.

------

The Company establishes its assumed insurance loss reserves for the estimated total unpaid costs of losses, including the loss adjustment expense ("LAE"). Loss and LAE reserves reflect management's best estimate of the total cost of (i) claims that have been incurred, but not yet paid in full, and (ii) claims that have been incurred but not yet reported to the Company. Reserves established by management represent an estimate of the outcome of future events and, as such, cannot be considered an exact calculation of the Company's liability. Rather, loss and LAE reserves represent management's best estimate of the Company's liability based on the application of actuarial techniques and other projection methodologies and taking into consideration other facts and circumstances known at the balance sheet date.

The Company engages the services of an outside actuarial consulting firm (the "Actuary") to assist on an annual basis to render an opinion on the sufficiency of the Company's estimates for unpaid losses and related LAE reserves. The Actuary utilizes both industry experience and the Company's own experience to develop estimates of those amounts as of year-end. These estimated liabilities are subject to the impact of future changes in claim severity, frequency and other factors. Despite the variability inherent in such estimates, management believes that the liabilities for unpaid losses and related LAE reserves are adequate. Unpaid losses and LAE reserves are included as a component of accrued expenses and other current liabilities on the condensed consolidated balance sheets.

**Cash and Cash Equivalents and Fiduciary Cash**

The Company considers all highly liquid short-term instruments with original maturities of three months or less to be cash equivalents. These instruments held by the Company included money market funds at September 30, 2025 and December 31, 2024, which are included as a component of cash and cash equivalents and fiduciary cash on the condensed consolidated balance sheets. Money market funds are carried at cost, which approximates fair value, and are considered Level 1 measurements within the fair value hierarchy. As of September 30, 2025 and December 31, 2024, the Company's money market funds totaled $213.0 million and $237.5 million, respectively.

**3. Business Combinations**

The Company completed two business combinations for an aggregate purchase price of $129.1 million during the nine months ended September 30, 2025. In accordance with ASC Topic 805, *Business Combinations* ("Topic 805"), total consideration was first allocated to the fair value of assets acquired, including liabilities assumed, with the excess being recorded as goodwill. For financial statement purposes, goodwill is not amortized but rather is evaluated for impairment at least annually or more frequently if an event or change in circumstances occurs that indicates goodwill may be impaired. For tax purposes, goodwill is generally deductible and will be amortized over a period of 15 years.

The Company completed the following business combinations during the nine months ended September 30, 2025:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Company acquired certain assets and equity interests of entities used in the operation of Bermuda-based reinsurance underwriting platform MultiStrat Group ("MultiStrat"), an Underwriting, Capacity & Technology Solutions partner effective April 1, 2025, to add an important capability to source alternative reinsurance capital for Baldwin's cedant clients and MSI, without taking balance sheet risk.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Company acquired from Hippo Holdings, Inc. ("Hippo") and its affiliates all the outstanding equity interests of the various entities comprising Hippo's homebuilder distribution network ("Hippo's Homebuilder Distribution Network"), a Mainstreet Insurance Solutions partner effective July 1, 2025. This partnership enhances Baldwin's ability to deliver property and casualty insurance solutions to homebuilder clients through expanded distribution capabilities. Refer to Note 4 for information regarding the Company's assumption of membership interests of a joint venture acquired as part of this partnership.

The recorded purchase price for business combinations may include an estimation of the fair value of contingent earnout obligations associated with contractual earnout provisions providing for post-closing contingent consideration payments, which are based on revenue, revenue growth and net income (loss) before interest, taxes, depreciation, amortization, and one-time transactional-related expenses or non-recurring items ("adjusted EBITDA") growth. The contingent earnout consideration amounts identified in the table below are measured at fair value within Level 3 of the fair value hierarchy as discussed further in Note 15. Any subsequent changes in the fair value of contingent earnout liabilities will be recorded in the condensed consolidated statements of comprehensive loss when incurred.

The recorded purchase price for the MultiStrat partnership also include an estimation of the fair value of equity interests, which is calculated based on the value of the Company's Class A common stock on the closing date taking into account a discount for lack of marketability.

------

In addition, the recorded purchase price allocation for Hippo's Homebuilder Distribution Network includes an estimation of the fair value of the pre-existing noncontrolling interest acquired in Lennar Insurance Agency. The fair value of the noncontrolling interest acquired in Lennar Insurance Agency was estimated using a discounted cash flow model under the income approach. The valuation relied on management-prepared financial projections and a discount rate consistent with market participant assumptions and the broader valuation of Hippo's Homebuilder Distribution Network.

The operating results of these business combinations have been included in the condensed consolidated statements of comprehensive loss since the acquisition date. The Company recognized total revenues and net income from its business combinations of $12.2 million and $2.7 million, respectively, for the three months ended September 30, 2025, and $14.2 million and $2.7 million, respectively, for the nine months ended September 30, 2025.

Due to the complexity of valuing the consideration paid and the purchase price allocation and the timing of these activities, certain amounts included in the consolidated financial statements may be provisional and subject to additional adjustments within the measurement period as permitted by Topic 805. Specifically, the Company's valuations of the fair value of contingent earnout consideration and intangible assets are estimates based on assumptions of factors such as discount rates and growth rates. Accordingly, these assets and liabilities are subject to measurement period adjustments as determined after the passage of time. Any measurement period adjustments related to prior period business combinations are reflected as current period adjustments in accordance with Topic 805.

The table below provides a summary of the total consideration and the estimated purchase price allocations made for each of the business acquisitions that became effective during the nine months ended September 30, 2025.

---

| | | | |
|:---|:---|:---|:---|
| **(in thousands)** | **MultiStrat** | **Hippo's Homebuilder Distribution Network** | **Totals** |
| Cash consideration paid | $12054 | $75345 | $87399 |
| Fair value of contingent earnout consideration | 8470 |  | 8470 |
| Fair value of equity interest | 863 |  | 863 |
| Deferred payment | 2901 | 29445 | 32346 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total consideration | $24288 | $104790 | $129078 |
| Recognized amounts of identifiable assets acquired and liabilities assumed: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash | $355 | $1533 | 1888 |
| &nbsp;&nbsp;&nbsp;&nbsp;Assumed premiums, commissions and fees receivable | 12190 | 1331 | 13521 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets | 1687 | 999 | 2686 |
| &nbsp;&nbsp;&nbsp;&nbsp;Intangible assets | 7167 | 111190 | 118357 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses and other current liabilities | (2744) | (852) | (3596) |
| &nbsp;&nbsp;&nbsp;&nbsp;Contingent earnout liability assumed |  | (9977) | (9977) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total identifiable net assets acquired | 18655 | 104224 | 122879 |
| &nbsp;&nbsp;&nbsp;&nbsp;Noncontrolling interest in partnership |  | (97920) | (97920) |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill | 5633 | 98486 | 104119 |
|  | $24288 | $104790 | $129078 |
| Maximum potential contingent earnout consideration | $16500 | <sup>(1)</sup> | <sup>(1)</sup> |

---

__________

(1)&nbsp;&nbsp;&nbsp;&nbsp;Hippo's Homebuilder Distribution Network has an uncapped earnout related to a previous business acquisition based on legacy account revenue.

The factors contributing to the recognition of goodwill are based on expanded product offerings, expanded distribution capabilities and vertical integration within the reinsurance and insurance brokerage industry.

------

The intangible assets acquired in connection with the partnerships have the following values and estimated weighted-average lives:

---

| | | |
|:---|:---|:---|
| **(in thousands, except weighted-average lives)** | **Amount** | **Weighted-Average Life** |
| Acquired relationships | $117070 | 10.0 years |
| Trade names | 550 | 5.0 years |
| Software<sup>(1)</sup> | 737 |  |

---

__________

(1)&nbsp;&nbsp;&nbsp;&nbsp;Software acquired in the MultiStrat partnership consists of internally-developed software, which will not be placed in service or amortized until it reaches technological feasibility.

Future annual estimated amortization expense for the next five years is as follows for intangible assets acquired in connection with the partnerships:

---

| | |
|:---|:---|
| **(in thousands)** | **Amount** |
| For the remainder of 2025 | $3444 |
| 2026 | 13811 |
| 2027 | 13861 |
| 2028 | 13621 |
| 2029 | 13164 |
| 2030 | 12527 |

---

The following pro forma consolidated results of operations are provided for illustrative purposes only and have been presented as if Hippo's Homebuilder Distribution Network occurred on January 1, 2024. This pro forma information should not be relied upon as being indicative of the historical results that would have been obtained if the acquisition had occurred on that date, nor of the results that may be obtained in the future.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For the Three Months<br> Ended September 30,** | **For the Three Months<br> Ended September 30,** | **For the Nine Months<br> Ended September 30,** | **For the Nine Months<br> Ended September 30,** |
| **(in thousands, except per share data)** | **2025** | **2024** | **2025** | **2024** |
| Pro forma results: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Revenues | $365389 | $346392 | $1172119 | $1080439 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss | (30237) | (13732) | (9767) | (5612) |

---

**4. Variable Interest Entities**

Topic 810 requires a reporting entity to consolidate a variable interest entity ("VIE") when the reporting entity has a variable interest or combination of variable interests that provide the entity with a controlling financial interest in the VIE. The Company continually assesses whether it has a controlling financial interest in each of its VIEs to determine if it is the primary beneficiary of the VIE and should, therefore, consolidate each of the VIEs. A reporting entity is considered to have a controlling financial interest in a VIE if it has (i) the power to direct the activities of a VIE that most significantly impact the VIE's economic performance, and (ii) the obligation to absorb the losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE.

As part of Hippo's Homebuilder Distribution Network partnership discussed further in Note 3, the Company acquired Hippo's 100% Class A membership interest (representing a 20% total interest) in Lennar Insurance Agency ("LIA"), a joint venture formed between Hippo and Lennar Title Group, LLC ("Lennar"), which holds 100% of the Class B membership interest (representing an 80% total interest). The joint venture was established to provide property and casualty insurance placement services to Lennar's homebuyers. The Company determined that LIA is a VIE under Topic 810 and that the Company is the primary beneficiary. As a result, LIA has been consolidated effective July 1, 2025, and its assets, liabilities, and results of operations are included in the Company's consolidated financial statements as of that date. The assets and liabilities of LIA and the noncontrolling interest in LIA issued to Lennar are included as a component of the purchase price allocation for Hippo's Homebuilder Distribution Network in Note 3.

------

In addition to LIA, the Company has determined that it is the primary beneficiary of its other VIEs, which include Laureate Insurance Partners, LLC, BKS Smith, LLC, BKS MS, LLC and BKS Partners Galati Marine Solutions, LLC. The Company has consolidated its VIEs into the accompanying condensed consolidated financial statements.

Total revenues and expenses of the Company's consolidated VIEs included in the condensed consolidated statements of comprehensive loss were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For the Three Months<br> Ended September 30,** | **For the Three Months<br> Ended September 30,** | **For the Nine Months<br> Ended September 30,** | **For the Nine Months<br> Ended September 30,** |
| **(in thousands, except per share data)** | **2025** | **2024** | **2025** | **2024** |
| Consolidated VIEs: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Revenues | $5167 | $593 | $6545 | $1798 |
| &nbsp;&nbsp;&nbsp;&nbsp;Expenses | 3989 | 239 | 4527 | 801 |

---

The assets of the consolidated VIEs can only be used to settle the obligations of the consolidated VIEs and the creditors of the liabilities of the consolidated VIEs do not have recourse to the Company.

**5. Revenue**

The following table provides disaggregated revenues by major source:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For the Three Months<br> Ended September 30,** | **For the Three Months<br> Ended September 30,** | **For the Nine Months<br> Ended September 30,** | **For the Nine Months<br> Ended September 30,** |
| **(in thousands)** | **2025** | **2024** | **2025** | **2024** |
| Commission revenue<sup>(1)(2)</sup> | $277439 | $270271 | $915544 | $873051 |
| Profit-sharing revenue<sup>(3)</sup> | 28719 | 26785 | 73019 | 69757 |
| Consulting and service fee revenue<sup>(4)</sup> | 26919 | 19257 | 74450 | 58011 |
| Policy fee and installment fee revenue<sup>(5)</sup> | 20599 | 16002 | 58263 | 43252 |
| Assumed premium earned<sup>(6)</sup> | 5863 |  | 15668 |  |
| Other income<sup>(7)</sup> | 2778 | 2895 | 12153 | 6338 |
| Investment income<sup>(8)</sup> | 3072 | 3728 | 8508 | 8736 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total revenues | $365389 | $338938 | $1157605 | $1059145 |

---

__________

(1)&nbsp;&nbsp;&nbsp;&nbsp;Commission revenue is earned by providing insurance placement services to clients under direct bill and agency bill arrangements with insurance company partners and reinsurance company partners for private risk management, commercial risk management, wealth management, employee benefits and Medicare insurance types.

(2)&nbsp;&nbsp;&nbsp;&nbsp;For the three months ended September 30, 2025 and 2024, commission revenue included direct bill revenue of $144.1 million and $141.6 million, respectively, and agency bill revenue of $133.4 million and $128.7 million, respectively. For the nine months ended September 30, 2025 and 2024, commission revenue included direct bill revenue of $487.2 million and $476.9 million, respectively, and agency bill revenue of $428.4 million and $396.1 million, respectively.

(3)&nbsp;&nbsp;&nbsp;&nbsp;Profit-sharing revenue represents bonus-type revenue that is earned by the Company as a sales incentive provided by certain insurance company partners.

(4)&nbsp;&nbsp;&nbsp;&nbsp;Service fee revenue is earned for providing insurance placement services to clients for a negotiated fee and consulting revenue is earned by providing specialty insurance consulting and other advisory services.

(5)&nbsp;&nbsp;&nbsp;&nbsp;Policy fee revenue represents revenue earned for acting in the capacity of an MGA and fulfilling certain administrative functions on behalf of insurance or reinsurance company partners, including delivery of policy documents, processing payments and other administrative functions. Installment fee revenue represents revenue earned by the Company for providing payment processing services on behalf of insurance company partners related to policy premiums paid on an installment basis.

(6)&nbsp;&nbsp;&nbsp;&nbsp;Assumed premium earned relates to the premiums earned in the Captive. Refer to Note 18 for additional information.

(7)&nbsp;&nbsp;&nbsp;&nbsp;Other income includes other ancillary income, premium financing income, and marketing income that is based on agreed-upon cost reimbursement for fulfilling specific targeted Medicare marketing campaigns.

(8)&nbsp;&nbsp;&nbsp;&nbsp;Investment income represents interest earnings on available cash invested in treasury money market funds.

The application of Topic 606 requires the use of management judgment. The following are the areas of most significant judgment as it relates to Topic 606:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Company considers the policyholders as representative of its customers in the majority of contractual relationships, with the exception of Medicare contracts in its Mainstreet Insurance Solutions operating group, where the insurance company partner is considered its customer.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Medicare contracts in the Mainstreet Insurance Solutions operating group are multi-year arrangements in which the Company is entitled to renewal commissions. However, the Company has applied a constraint to renewal commissions that limits revenue recognized when a risk of significant reversals exists based on: (i) historical renewal patterns; and (ii) the influence of external factors outside of the Company's control, including policyholder discretion over plans and insurance company partner relationship, political influence, and a contractual provision, which limits the Company's right to receive renewal commissions to ongoing compliance and regulatory approval of the relevant insurance company partner and compliance with the Centers for Medicare and Medicaid Services.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Company recognizes separately contracted commission revenue at the effective date of insurance placement and considers any ongoing interaction with the customer to be insignificant in the context of the obligations of the contract.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Variable consideration includes estimates of direct bill commissions, reserves for policy cancellations and accruals for profit-sharing income.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Costs to obtain a contract are deferred and recognized over five years, which represents management's estimate of the average benefit period for new business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Due to the relatively short time period between the information gathering phase and binding insurance coverage, the Company has determined that costs to fulfill contracts are not significant. Therefore, costs to fulfill a contract are expensed as incurred.

**6. Contract Assets and Liabilities**

Contract assets arise when the Company recognizes revenue for amounts that have not yet been billed. Contract liabilities relate to payments received in advance of performance under the contract before the transfer of a good or service to the customer. Contract assets are included in assumed premiums, commissions and fees receivable, net and contract liabilities are included in accrued expenses and other current liabilities on the condensed consolidated balance sheets. The balances of contract assets and liabilities arising from contracts with customers were as follows:

---

| | | |
|:---|:---|:---|
| **(in thousands)** | **September 30, 2025** | **December 31, 2024** |
| Contract assets | $294720 | $249579 |
| Contract liabilities | 38516 | 40780 |

---

During the nine months ended September 30, 2025, the Company recognized revenue of $38.1 million related to the contract liabilities balance at December 31, 2024.

**7. Deferred Commission Expense**

The Company pays an incremental amount of compensation in the form of producer commissions on new business. In accordance with ASC Topic 340, *Other Assets and Deferred Costs,* these incremental costs are deferred and amortized over five years, which represents management's estimate of the average benefit period for new business. Deferred commission expense represents producer commissions that are capitalized and not yet expensed and are included in other assets on the condensed consolidated balance sheets. The table below provides a rollforward of deferred commission expense:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For the Three Months<br> Ended September 30,** | **For the Three Months<br> Ended September 30,** | **For the Nine Months<br> Ended September 30,** | **For the Nine Months<br> Ended September 30,** |
| **(in thousands)** | **2025** | **2024** | **2025** | **2024** |
| Balance at beginning of period | $37479 | $29434 | $33844 | $26205 |
| &nbsp;&nbsp;&nbsp;&nbsp;Costs capitalized | 3965 | 5930 | 13554 | 13547 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization | (3299) | (2638) | (9253) | (7026) |
| Balance at end of period | $38145 | $32726 | $38145 | $32726 |

---

------

**8. Goodwill**

The changes in carrying value of goodwill by operating group for the periods are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **(in thousands)** | **Insurance Advisory Solutions** | **Underwriting, Capacity & Technology Solutions** | **Mainstreet Insurance Solutions** | **Total** |
| Balance at December 31, 2024 | $932487 | $235589 | $244293 | $1412369 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill of acquired businesses |  | 5633 | 98486 | 104119 |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at September 30, 2025 | $932487 | $241222 | $342779 | $1516488 |

---

**9. Accrued Expenses and Other Current Liabilities**

Accrued expenses and other current liabilities consist of the following:

---

| | | |
|:---|:---|:---|
| **(in thousands)** | **September 30, 2025** | **December 31, 2024** |
| Accrued compensation and benefits | $68007 | $67036 |
| Accrued expenses | 29471 | 12351 |
| Deferred payment | 29336 | 123 |
| Contract liabilities | 38516 | 40780 |
| Accrued interest | 19471 | 6194 |
| Current portion of operating lease liabilities | 17597 | 17078 |
| Current portion of long-term debt | 10061 | 8400 |
| Other | 9206 | 8669 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses and other current liabilities | $221665 | $160631 |

---

**10. Long-Term Debt**

As of December 31, 2024, the Amended and Restated Credit Agreement provided for senior secured credit facilities in an aggregate principal amount of $1.44 billion, which consisted of (i) a term loan facility in the principal amount of $840 million, bearing interest at a rate of term SOFR, plus an applicable margin of 325 bps, with a margin step-down to 300 bps at a first lien net leverage ratio of 4.00x or below, maturing May 24, 2031 (the "2024 Term Loan Facility" and the loans thereunder, the "2024 Term Loans") and (ii) a revolving credit facility with commitments in an aggregate principal amount of $600 million, bearing interest at SOFR plus 210 bps to SOFR plus 310 bps based on total net leverage ratio maturing May 24, 2029 (the "Revolving Facility" and, together with the 2024 Term Loan Facility, the "2024 Credit Facility"). As of December 31, 2024, Baldwin Holdings also had 7.125% Senior Secured Notes with an aggregate principal amount of $600 million due May 15, 2031.

On January 10, 2025, the 2024 Credit Agreement, the definitive agreement for the 2024 Credit Facility, was amended to, among other things, provide for $100.0 million of incremental term B loans (the loans thereunder, the "Existing 2025 Term Loans"), increasing the aggregate principal amount of Baldwin Holdings' existing $835.8 million senior secured first lien term loan facility to $935.8 million (the "January 2025 Refinancing"). The proceeds of the 2025 Existing Term Loans were used to repay in full all of the 2024 Term Loans outstanding under the 2024 Credit Agreement.

Under the January 2025 Refinancing, the Existing 2025 Term Loans bore interest at term SOFR, plus an applicable margin of 300 bps, with a margin step-down to 275 bps at a first lien net leverage ratio of 4.00x or below. The Existing 2025 Term Loans were otherwise subject to the same terms to which the 2024 Term Loans were subject under the 2024 Credit Agreement.

On September 18, 2025, the 2024 Credit Agreement was amended to, among other things, (i) reprice the Existing 2025 Term Loans; (ii) provide for $75.0 million of incremental term B loans (the "New Term Loans" and together with the Existing 2025 Term Loans, the "Term Loans"), increasing the aggregate principal amount of the Term Loans from $931.1 million to $1.006 billion; and (iii) reduce the applicable margin for the Revolving Facility (together, the "September 2025 Refinancing" and, together with the January 2025 Refinancing, the "2025 Refinancings"). The proceeds of the New Term Loans were used to pay down outstanding borrowings under the Revolving Facility.

------

Under the September 2025 Refinancing, the Term Loans bear interest at term SOFR, plus an applicable margin of 250 bps. The New Term Loans are otherwise subject to the same terms to which the Existing 2025 Term Loans were subject under the Credit Agreement. The interest rate for the 2024 Revolving Facility is term SOFR, plus a credit spread adjustment of 10 bps, plus an applicable margin of 175 bps to 250 bps based on a total first lien net leverage ratio.

As of September 30, 2025 and December 31, 2024, the Company's outstanding borrowings under the 2025 Term Loans and 2024 Term Loans of $1.004 billion and $835.8 million, respectively, had an applicable interest rate of 6.64% and 7.61%, respectively. Outstanding borrowings under the Revolving Facility of $66.0 million at September 30, 2025 had an applicable interest rate of 6.82%. There were no outstanding borrowings under the Revolving Facility at December 31, 2024. The Revolving Facility was subject to a commitment fee of 0.40% on unused capacity as of September 30, 2025 and December 31, 2024. At September 30, 2025 and December 31, 2024, the Company had undrawn letters of credit issued under the Revolving Facility of $10.0 million and $12.0 million, respectively, which are subject to letter of credit fees.

**11. Derivative Instruments and Hedging**

The Company is exposed to interest rate risk resulting from its long-term debt and revolving facility. The Company uses derivative instruments, including, from time to time, interest rate caps and swaps, to mitigate its exposure to variability in cash flows due to changes in interest rates on its floating-rate debt. However, the Company does not use derivative instruments for trading or speculative purposes.

Effective September 14, 2025, the Company entered into a floating-to-fixed interest rate swap agreement with a notional amount of $500.0 million, which exchanges the variable rate of the Term Loans, which are indexed to 1-month term SOFR, for a fixed rate of 3.244%. Interest payments will be made on a monthly basis commencing on October 14, 2025 through the termination date of September 14, 2028.

The interest rate swap has been designated as a cash flow hedge under ASC 815, *Derivatives and Hedging*. The Company assesses hedge effectiveness using the hypothetical derivative method and expects the hedge to be highly effective over its term. Changes in the fair value of the interest rate swap are recorded in accumulated other comprehensive income ("AOCI"), which is a component of equity on the condensed consolidated balance sheets, and reclassified into interest expense, net in the condensed consolidated statements of comprehensive loss in the same period the hedged interest payments affect earnings. The net cash settlements of the interest rate swap are classified within cash flows from operating activities in the condensed consolidated statements of cash flows. The Company's hedging program extends through September 2028.

At September 30, 2025, the fair value of the interest rate swap was a $1.3 million asset, which is included in other assets on the condensed consolidated balance sheets. The Company recorded a $1.0 million gain in AOCI related to the interest rate swap during each of the three and nine months ended September 30, 2025. The Company estimates $2.0 million of net gains on the interest rate swap to be reclassified from AOCI to interest expense over the next twelve months.

**12. Related Party Transactions**

**Related Party Balances**

Baldwin Holdings holds an investment in Emerald Bay Risk Solutions, LLC ("Emerald Bay"), an entity formed for the benefit of the MGA business, and to which Baldwin Holdings, Lowry Baldwin, the Company's Chairman, and members of the Company's executive management team have made capital commitments. The carrying value of the Company's investment in Emerald Bay was $2.3 million and $2.1 million at September 30, 2025 and December 31, 2024, respectively. Investments are included in other assets on the condensed consolidated balance sheets.

Related party notes payable of $5.6 million at December 31, 2024 relate to the settlement of contingent earnout consideration through the issuance of related party notes payable for one of the Company's partners. These related party notes payable were subsequently paid in the first quarter of 2025.

**Commission Revenue**

The Company serves as a broker for Holding Company of the Villages, Inc. ("The Villages"), a significant shareholder, and certain affiliated entities. Commission revenue recorded from transactions with The Villages and affiliated entities was $1.0 million and $0.1 million for the three months ended September 30, 2025 and 2024, respectively, and $3.0 million and $2.4 million for the nine months ended September 30, 2025 and 2024, respectively.

------

**Commissions Expense**

Two brothers of Lowry Baldwin, the Company's Chairman, collectively received producer commissions from the Company comprising approximately $0.2 million and $0.1 million for the three months ended September 30, 2025 and 2024, respectively, and $0.4 million and $0.4 million during the nine months ended September 30, 2025 and 2024, respectively.

**Rent Expense**

The Company has various agreements to lease office space from wholly-owned subsidiaries of The Villages. Total rent expense incurred with respect to The Villages and its wholly-owned subsidiaries was approximately $0.2 million and $0.1 million for the three months ended September 30, 2025 and 2024, respectively, and $0.6 million and $0.4 million for the nine months ended September 30, 2025 and 2024, respectively. Total right-of-use assets and operating lease liabilities included on the Company's condensed consolidated balance sheets relating to these lease agreements were $0.9 million and $0.9 million, respectively, at September 30, 2025 and $1.3 million and $1.4 million, respectively, at December 31, 2024.

The Company has various agreements to lease office space from other related parties. Total rent expense incurred with respect to other related parties was $0.7 million and $0.9 million for the three months ended September 30, 2025 and 2024, and $2.5 million and $2.8 million for the nine months ended September 30, 2025 and 2024, respectively. Total right-of-use assets and operating lease liabilities included on the Company's condensed consolidated balance sheets relating to these lease agreements were $7.8 million and $9.2 million, respectively, at September 30, 2025 and $9.7 million and $10.3 million, respectively, at December 31, 2024.

**13. Share-Based Compensation**

The Company has an Omnibus Incentive Plan (the "Omnibus Plan") and a Partnership Inducement Award Plan (the "Inducement Plan" and, collectively with the Omnibus Plan, the "Plans") to motivate and reward colleagues and certain other individuals to perform at the highest level and contribute significantly to the Company's success, thereby furthering the best interests of Baldwin's stockholders. The total number of shares of Class A common stock authorized for issuance under the Omnibus Plan and the Inducement Plan was 13,143,677 and 3,000,000, respectively, at September 30, 2025.

During the nine months ended September 30, 2025, the Company made awards of restricted stock awards ("RSAs"), performance-based restricted stock unit awards ("PSUs"), and fully vested shares under the Plans to its non-employee directors, officers, colleagues and consultants. Fully-vested shares issued to directors, officers and colleagues during the nine months ended September 30, 2025 were vested upon issuance and PSUs issued to officers vest in the quarter following the end of a performance period of three years, while RSAs issued to colleagues, consultants and officers generally either cliff vest after three to four years or vest ratably over three to five years.

The following table summarizes the activity for awards granted by the Company under the Plans:

---

| | | |
|:---|:---|:---|
| | **Shares** | **Weighted-Average Grant-Date Fair Value Per Share** |
| Non-vested awards outstanding at December 31, 2024 | 3471382 | $31.08 |
| &nbsp;&nbsp;&nbsp;&nbsp;Granted | 1696160 | 42.06 |
| &nbsp;&nbsp;&nbsp;&nbsp;Vested and settled | (1608655) | 32.30 |
| &nbsp;&nbsp;&nbsp;&nbsp;Forfeited | (174291) | 31.08 |
| Non-vested awards outstanding at September 30, 2025 | 3384596 | 36.00 |

---

The total fair value of shares that vested and settled under the Plans was $52.0 million and $36.7 million for the nine months ended September 30, 2025 and 2024, respectively.

Share-based compensation is recognized ratably over the vesting period of the respective awards and includes expense related to issuances under the Plans, as well as the portion of annual bonuses that are payable in fully-vested shares of Class A common stock. The Company recognizes share-based compensation expense for the Plans net of actual forfeitures. The Company recorded share-based compensation expense of $22.0 million and $17.9 million for the three months ended September 30, 2025 and 2024, respectively, and $51.8 million and $46.8 million for the nine months ended September 30, 2025 and 2024, respectively. Share-based compensation expense is included in colleague compensation and benefits expense in the condensed consolidated statements of comprehensive loss.

------

**14. Earnings (Loss) Per Share**

Basic earnings (loss) per share is computed by dividing net income (loss) attributable to Baldwin by the weighted-average number of shares of Class A common stock outstanding during the period. Diluted earnings (loss) per share is computed giving effect to all potentially dilutive shares of common stock.

The following table sets forth the computation of basic and diluted loss per share:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For the Three Months<br> Ended September 30,** | **For the Three Months<br> Ended September 30,** | **For the Nine Months<br> Ended September 30,** | **For the Nine Months<br> Ended September 30,** |
| **(in thousands, except per share data)** | **2025** | **2024** | **2025** | **2024** |
| Basic and diluted loss per share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss attributable to Baldwin | $(18727) | $(8377) | $(7952) | $(4356) |
| &nbsp;&nbsp;&nbsp;&nbsp;Shares used for basic and diluted loss per share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic and diluted weighted-average shares of Class A common stock outstanding | 68605 | 64012 | 67572 | 63001 |
| Basic and diluted loss per share | $(0.27) | $(0.13) | $(0.12) | $(0.07) |

---

Potentially dilutive securities consist of unvested stock awards, including RSAs and PSUs, in addition to shares of Class B common stock, which can be exchanged (together with a corresponding number of LLC Units) for shares of Class A common stock on a one-for-one basis. The following potentially dilutive securities were excluded from the Company's diluted weighted-average number of shares outstanding calculation for the periods presented as their inclusion would have been anti-dilutive.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For the Three Months<br> Ended September 30,** | **For the Three Months<br> Ended September 30,** | **For the Nine Months<br> Ended September 30,** | **For the Nine Months<br> Ended September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Unvested RSAs and PSUs | 3265420 | 4014508 | 3320275 | 3569891 |
| Shares of Class B common stock | 47233760 | 50490324 | 47990925 | 51234449 |

---

The shares of Class B common stock do not share in the earnings or losses attributable to Baldwin, and therefore, are not participating securities. Accordingly, a separate presentation of basic and diluted loss per share of Class B common stock under the two-class method has not been included.

**15. Fair Value Measurements**

ASC Topic 820, *Fair Value Measurement* ("Topic 820") established a framework for measuring fair value. That framework provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The three levels of the fair value hierarchy under Topic 820 are described below:

Level 1:&nbsp;&nbsp;&nbsp;&nbsp;Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the Company has the ability to access.

Level 2:&nbsp;&nbsp;&nbsp;&nbsp;Inputs to the valuation methodology are quoted market prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market.

Level 3:&nbsp;&nbsp;&nbsp;&nbsp;Inputs to the valuation methodology are unobservable and significant to the fair value measurement.

The fair value measurement level for assets and liabilities within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs.

------

**Assets and Liabilities Measured at Fair Value on a Recurring Basis**

The following table summarizes the Company's assets and liabilities measured at fair value on a recurring basis within each level of the fair value hierarchy:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Fair Value Hierarchy** | **Fair Value Hierarchy** | **Fair Value Hierarchy** | **Fair Value Hierarchy** | **Fair Value Hierarchy** | **Fair Value Hierarchy** |
| | **Level 1** | **Level 1** | **Level 2** | **Level 2** | **Level 3** | **Level 3** |
| **(in thousands)** | **September 30, 2025** | **December 31, 2024** | **September 30, 2025** | **December 31, 2024** | **September 30, 2025** | **December 31, 2024** |
| Assets: |  |  |  |  |  |  |
| Derivative instruments | $— | $— | $1251 | $18 | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;Total assets measured at fair value | $— | $— | $1251 | $18 | $— | $— |
| Liabilities: |  |  |  |  |  |  |
| Contingent earnout liabilities | $— | $— | $— | $— | $28392 | $145559 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total liabilities measured at fair value | $— | $— | $— | $— | $28392 | $145559 |

---

***Derivative Instruments***

Derivative instruments include interest rate swaps and interest rate caps. The fair value of interest rate swap is determined using an income approach based on the terms of the interest rate swap and inputs corroborated by observable market data, including interest rate curves. The fair value of interest rate caps is determined using the market standard methodology of discounting the future expected cash receipts that would occur if variable interest rates rise above the strike rate of the caps. The variable interest rates used in the calculation of projected receipts on the caps are based on an expectation of future interest rates derived from observable market interest rate curves and volatilities. Derivative instruments are classified within Level 2 of the fair value hierarchy.

***Contingent Earnout Liabilities***

Methodologies used for liabilities measured at fair value on a recurring basis within Level 3 of the fair value hierarchy are based on limited unobservable inputs. These methods may produce a fair value calculation that may not be indicative of the net realizable value or reflective of future fair values. Furthermore, while the Company believes its valuation methods are appropriate and consistent with other market participants, the use of methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.

The fair value of contingent earnout liabilities is based on sales projections for the acquired entities, which are reassessed each reporting period. Based on the Company's ongoing assessment of the fair value of its contingent earnout liabilities, the Company recorded a net increase in the estimated fair value of such liabilities of $2.0 million and $8.1 million for the three and nine months ended September 30, 2025, respectively. The Company has assessed the maximum estimated exposure to the contingent earnout liabilities to be $65.5 million at September 30, 2025.

The Company measures contingent earnout liabilities at fair value each reporting period using significant unobservable inputs classified within Level 3 of the fair value hierarchy. The Company uses a probability weighted value analysis as a valuation technique to convert future estimated cash flows to a single present value amount. The significant unobservable inputs used in the fair value measurements are sales projections over the earnout period, and the probability outcome percentages assigned to each scenario. Significant increases or decreases to either of these inputs would result in a significantly higher or lower liability with a higher liability capped by the contractual maximum of the contingent earnout liabilities. Ultimately, the liability will be equivalent to the amount settled, and the difference between the fair value estimate and amount settled will be recorded in earnings for business combinations, or as a change in the carrying value of the assets acquired for asset acquisitions.

------

The fair value of the contingent earnout liabilities is based on estimating the present value of the expected future payments to be made to partners in accordance with the provisions outlined in the respective purchase agreements, which at times includes Monte Carlo simulations or a discounted cash flow analysis. In determining fair value, the Company estimates the partner's future performance using financial projections developed by management for the partner and market participant assumptions that were derived for revenue growth, EBITDA growth and retention rates. Revenue or EBITDA growth rates for earnouts with ongoing measurement periods were generally 20% at September 30, 2025 and from 20% to 25% at December 31, 2024. The Company estimates future payments using the earnout formula and performance targets specified in each purchase agreement and these financial projections. These payments are generally discounted to present value using a risk-adjusted rate that takes into consideration market-based rates of return that reflect the ability of the partner to achieve the targets. However, no significant discount rates have been applied to the remaining material contingent earnout liabilities at September 30, 2025 or December 31, 2024 due, in part, to the short-term nature of a substantial portion of the liabilities wherein their fair values approximate their carrying values. Changes in financial projections, market participant assumptions for revenue growth, or the risk-adjusted discount rate, would result in a change in the fair value of contingent consideration.

The following table sets forth a summary of the changes in the fair value of the Company's contingent earnout liabilities, which are measured at fair value on a recurring basis utilizing Level 3 assumptions in their valuation:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For the Three Months<br> Ended September 30,** | **For the Three Months<br> Ended September 30,** | **For the Nine Months<br> Ended September 30,** | **For the Nine Months<br> Ended September 30,** |
| **(in thousands)** | **2025** | **2024** | **2025** | **2024** |
| Balance at beginning of period | $16731 | $210243 | $145559 | $276467 |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of contingent consideration<sup>(1)</sup> | 1980 | (952) | 8084 | 17276 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fair value of contingent consideration issuances | 9681 |  | 18447 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Settlement of contingent consideration<sup>(2)</sup> |  | (5501) | (143698) | (89953) |
| Balance at end of period | $28392 | $203790 | $28392 | $203790 |

---

__________

(1)&nbsp;&nbsp;&nbsp;&nbsp;The Company reclassified $(1.8) million of its contingent earnout liabilities through the issuance/(reduction) of colleague earnout incentives during the nine months ended September 30, 2025, and $4.3 million and $10.7 million during the three and nine months ended September 30, 2024, respectively, which results in a reclassification between the change in fair value of contingent consideration and colleague compensation and benefits expense in the condensed consolidated statements of comprehensive loss.

(2)&nbsp;&nbsp;&nbsp;&nbsp;The Company settled $5.6 million of its contingent earnout liabilities through the issuance of related party notes payable during the nine months ended September 30, 2024. The condensed consolidated statements of cash flows for the nine months ended September 30, 2025 and 2024 include $5.6 million and $1.5 million, respectively, of payments of contingent earnout consideration related to similar non-cash settlements in prior periods.

**Fair Value of Other Financial Instruments**

The fair value of long-term debt is based on an estimate using a discounted cash flow analysis and current borrowing rates for similar types of borrowing arrangements. The carrying amount and estimated fair value of long-term debt were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Fair Value Hierarchy** | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
| **(in thousands)** | **Fair Value Hierarchy** | **Carrying Amount** | **Estimated <br>Fair Value** | **Carrying Amount** | **Estimated <br>Fair Value** |
| Long-term debt<sup>(1)</sup> | Level 2 | $1603606 | $1626106 | $1435800 | $1450479 |
| Revolving line of credit | Level 2 | 66000 | 66868 |  |  |

---

__________

(1)&nbsp;&nbsp;&nbsp;&nbsp;The carrying amount of long-term debt reflects outstanding borrowings, which are presented net of unamortized debt issuance costs of $26.0 million and $29.3 million at September 30, 2025 and December 31, 2024, respectively, on the condensed consolidated balance sheets.

**16. Commitments and Contingencies**

**Commitments**

As of September 30, 2025, Baldwin Holdings has a remaining commitment to the University of South Florida ("USF") to donate $3.4 million through October 2028. The gift will provide support for the School of Risk Management and Insurance in the USF Muma College of Business. It is currently anticipated that Lowry Baldwin, the Company's Chairman, will fund half of the amounts to be donated by Baldwin Holdings.

------

**Legal Proceedings**

The Company is involved in various claims and legal actions arising in the ordinary course of business. A liability is recorded when a loss is considered probable and is reasonably estimable in accordance with GAAP. When a material loss contingency is reasonably possible but not probable, the Company will disclose the nature of the claim and, if possible, an estimate of the loss or range of loss. In the opinion of management, the ultimate resolution of these matters will not have a material adverse effect on the Company's consolidated financial position, results of operations or liquidity.

On February 8, 2023, Ruby Wagner, a putative Class A stockholder of the Company, filed a class action lawsuit (the "Lawsuit"), on behalf of herself and other similarly situated stockholders in the Delaware Court of Chancery against the Company seeking declaratory judgment that certain provisions of the 2019 Stockholders Agreement between the Company and the Pre-IPO LLC Members are invalid and unenforceable as a matter of Delaware law. On May 28, 2024, the Court of Chancery issued an opinion (the "Chancery Court Opinion") that certain provisions of the 2019 Stockholders Agreement granting approval rights related to amending the Company's certificate of incorporation and making significant decisions relating to the Company's senior management, are facially invalid, void, and unenforceable under Delaware law. An implementing order, presently in effect, was entered on June 20, 2024. The Chancery Court Opinion also held that a severability provision in the 2019 Stockholders Agreement allows the Pre-IPO LLC Members to demand a "suitable and equitable substitute" for the approval rights that were deemed invalid, such as the issuance of a so-called golden share of preferred stock in the Company. Following the Chancery Court Opinion, a counterparty to the 2019 Stockholders Agreement requested the issuance of such golden share. An independent committee of the Company's board of directors, advised by independent counsel, determined that entering into a contractual agreement containing substantially the same rights as those contained in the 2019 Stockholders Agreement, as authorized by a newly-enacted provision of Delaware law, rather than issuance of a golden share, would be in the best interests of the Company and its stockholders and, following negotiation, the Company entered into the 2024 Stockholders Agreement on October 30, 2024. On January 22, 2025, the Court of Chancery granted plaintiff an award of attorneys' fees and expenses in the amount of $2.4 million (the "Fee Award"). On February 21, 2025, the Company filed an appeal from the Chancery Court Opinion and the Fee Award with the Delaware Supreme Court. Due to the Company's appeal, management has estimated the potential range of loss from the ultimate disposition of this matter to be between $0, if the appeal is successful, and $2.4 million, if the Fee Award is upheld, a significant portion of which may be covered by insurance.

**17. Segment Information**

Baldwin's business is divided into three operating groups: Insurance Advisory Solutions, Underwriting, Capacity & Technology Solutions and Mainstreet Insurance Solutions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Insurance Advisory Solutions ("IAS") operating group provides expertly-designed commercial risk management, employee benefits and private risk management solutions for businesses and high-net-worth individuals, as well as their families, through its national footprint, which has assimilated some of the highest quality independent insurance brokers in the country with vast and varied strategic capabilities and expertise.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Underwriting, Capacity & Technology Solutions ("UCTS") operating group consists of three distinct divisions—its MGA platform, MSI; its Capacity Solutions group (which consists of its reinsurance brokerage business, Juniper Re; its reinsurance MGA business, MultiStrat; and its captive management business); and the Captives. Through MSI, the Company manufactures proprietary, technology-enabled insurance products that are then distributed (in many instances via technology and/or API integrations) internally via risk advisors across its other operating groups and externally via select distribution partners, with a focus on sheltered channels where its products deliver speed, ease of use and certainty of execution, an example of which is the national embedded renters insurance product sold at point of lease via integrations with property management software providers. UCTS' Wholesale Business was sold in the first quarter of 2024, and its operations are included in UCTS' results through February 29, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Mainstreet Insurance Solutions ("MIS") operating group offers personal insurance, commercial insurance and life and health solutions to individuals and businesses in their communities, with a focus on accessing clients via sheltered distribution channels, which include, but are not limited to, new home builders, realtors, mortgage originators/lenders, master planned communities, and various other community centers of influence. The MIS operating group also offers consultation for government assistance programs and solutions, including traditional Medicare, Medicare Advantage and Affordable Care Act, to seniors and eligible individuals through a network of primarily independent contractor agents.

In all its operating groups, the Company generates commissions from insurance placement under both agency bill and direct bill arrangements, and profit-sharing income based on either the underlying book of business or performance, such as loss ratios. All operating groups also generate other ancillary income.

------

In the IAS and UCTS operating groups, the Company generates fees from service fee and consulting arrangements. Service fee arrangements are in place with certain clients for providing insurance placement services.

In the UCTS operating group, the Company generates fees from policy fee and installment fee arrangements. Policy fee revenue is earned for acting in the capacity of an MGA and providing payment processing services and other administrative functions on behalf of insurance or reinsurance company partners. Additionally, the UCTS operating group generates assumed premium earned through the Captive business.

In the MIS operating group, the Company generates commissions and fees from marketing income, which is earned through co-branded Medicare marketing campaigns with the Company's insurance company partners.

In addition, the Company generates investment income in all of its operating groups and the Corporate and Other non-reportable segment.

The Company's chief operating decision maker, the chief executive officer, evaluates the performance of the Company's operating groups based on net income (loss) and adjusted EBITDA. The chief operating decision maker considers actual, actual-to-prior year variances, and budget-to-actual variances on a monthly basis for both profit measures to manage resources and make decisions about the business. However, only operating group net income (loss), as the measure of segment profit or loss that is most consistent with GAAP measurement principles, is disclosed below.

Summarized financial information regarding the Company's operating groups is shown in the following tables. Corporate and Other includes any expenses not allocated to the operating groups and corporate-related items, including interest expense. Intersegment revenue and expenses are eliminated through Corporate and Other. Service center expenses and other overhead are allocated to the Company's operating groups based on either revenue or headcount as applicable to each expense.

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** |
| **(in thousands)** | **Insurance Advisory Solutions** | **Underwriting, Capacity & <br>Technology Solutions** | **Mainstreet Insurance Solutions** | **Corporate<br>and Other** | **Total** |
| &nbsp;&nbsp;&nbsp;Revenues: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Commission revenue<sup>(1)(2)</sup> | $116878 | $112260 | $65403 | $(17102) | $277439 |
| &nbsp;&nbsp;&nbsp;&nbsp;Profit-sharing revenue | 13763 | 5276 | 9680 |  | 28719 |
| &nbsp;&nbsp;&nbsp;&nbsp;Consulting and service fee revenue | 25344 | 1575 |  |  | 26919 |
| &nbsp;&nbsp;&nbsp;&nbsp;Policy fee and installment fee revenue |  | 20599 |  |  | 20599 |
| &nbsp;&nbsp;&nbsp;&nbsp;Assumed premium earned |  | 5863 |  |  | 5863 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income | 1155 | 353 | 1346 | (76) | 2778 |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment income | 1380 | 1341 | 47 | 304 | 3072 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | 158520 | 147267 | 76476 | (16874) | 365389 |
| Expenses: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Inside advisor commissions | 40096 | 191 | 7571 |  | 47858 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed compensation | 56609 | 16346 | 10525 | 3233 | 86713 |
| &nbsp;&nbsp;&nbsp;&nbsp;Benefits and other | 17764 | 7773 | 6466 | 2820 | 34823 |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation | 8436 | 5097 | 1952 | 6532 | 22017 |
| &nbsp;&nbsp;&nbsp;&nbsp;Severance | 587 | 968 | 7 | 58 | 1620 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Colleague compensation and benefits | 123492 | 30375 | 26521 | 12643 | 193031 |
| &nbsp;&nbsp;&nbsp;&nbsp;Outside commissions<sup>(2)</sup> | 2151 | 75492 | 18646 | (17178) | 79111 |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling expense | 5716 | 1522 | 3363 | 2289 | 12890 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating expense | 13336 | 16757 | 6123 | 6237 | 42453 |
| &nbsp;&nbsp;&nbsp;&nbsp;Administrative expense | 13858 | 5901 | 11205 | 36166 | 67130 |
| &nbsp;&nbsp;&nbsp;&nbsp;All other expenses, net<sup>(3)</sup> | 412 | 357 | 156 | 86 | 1011 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total expense | 158965 | 130404 | 66014 | 40243 | 395626 |
| Net income (loss) | $(445) | $16863 | $10462 | $(57117) | $(30237) |
| Other segment disclosures: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of contingent consideration | $1533 | $447 | $— | $— | $1980 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization expense | 13629 | 5581 | 11177 | 1656 | 32043 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense, net |  | 100 | 16 | 31016 | 31132 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on extinguishment and modification of debt |  |  |  | 3290 | 3290 |

---

__________

(1)&nbsp;&nbsp;&nbsp;&nbsp;During the three months ended September 30, 2025, commission revenue for the IAS, UCTS and MIS operating groups included direct bill revenue of $73.8 million, $5.3 million and $64.9 million, respectively, and agency bill revenue of $43.1 million, $107.0 million and $0.5 million, respectively.

(2)&nbsp;&nbsp;&nbsp;&nbsp;During the three months ended September 30, 2025, the IAS operating group recorded commission revenue shared with other operating groups of $0.1 million and the UCTS operating group recorded commission revenue shared with other operating groups of $17.1 million. Commission revenue shared with other operating groups, and the related outside commissions, are eliminated through Corporate and Other.

(3)&nbsp;&nbsp;&nbsp;&nbsp;All other expenses, net include change in fair value of contingent consideration, gain (loss) on divestitures, other income (expense), net and income tax expense.

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** |
| **(in thousands)** | **Insurance Advisory Solutions** | **Underwriting, Capacity & <br>Technology Solutions** | **Mainstreet Insurance Solutions** | **Corporate<br>and Other** | **Total** |
| &nbsp;&nbsp;&nbsp;Revenues: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Commission revenue<sup>(1)(2)</sup> | $123468 | $106521 | $61983 | $(21701) | $270271 |
| &nbsp;&nbsp;&nbsp;&nbsp;Profit-sharing revenue | 15543 | 4066 | 7176 |  | 26785 |
| &nbsp;&nbsp;&nbsp;&nbsp;Consulting and service fee revenue | 17701 | 1556 |  |  | 19257 |
| &nbsp;&nbsp;&nbsp;&nbsp;Policy fee and installment fee revenue |  | 16002 |  |  | 16002 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income | 823 | 573 | 1499 |  | 2895 |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment income | 1803 | 1076 |  | 849 | 3728 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | 159338 | 129794 | 70658 | (20852) | 338938 |
| Expenses: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Inside advisor commissions | 33676 | 199 | 7163 |  | 41038 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed compensation | 52550 | 13854 | 9526 | 1434 | 77364 |
| &nbsp;&nbsp;&nbsp;&nbsp;Benefits and other | 18395 | 7358 | 5205 | 331 | 31289 |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation | 7513 | 1887 | 1099 | 7450 | 17949 |
| &nbsp;&nbsp;&nbsp;&nbsp;Severance | 254 | 319 | 105 |  | 678 |
| &nbsp;&nbsp;&nbsp;&nbsp;Colleague earnout incentives | 4327 |  |  |  | 4327 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Colleague compensation and benefits | 116715 | 23617 | 23098 | 9215 | 172645 |
| &nbsp;&nbsp;&nbsp;&nbsp;Outside commissions<sup>(2)</sup> | 2551 | 74420 | 19274 | (21701) | 74544 |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling expense | 5251 | 1142 | 3982 | 1697 | 12072 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating expense | 14588 | 9866 | 5064 | 6533 | 36051 |
| &nbsp;&nbsp;&nbsp;&nbsp;Administrative expense | 17016 | 4043 | 6616 | 33129 | 60804 |
| &nbsp;&nbsp;&nbsp;&nbsp;All other expenses (income), net<sup>(3)</sup> | (5982) | 3011 | 225 | 43 | (2703) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total expense | 150139 | 116099 | 58259 | 28916 | 353413 |
| Net income (loss) | $9199 | $13695 | $12399 | $(49768) | $(14475) |
| Other segment disclosures: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of contingent consideration | $(4195) | $3032 | $211 | $— | $(952) |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization expense | 16798 | 4001 | 6558 | 1099 | 28456 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense (income), net | (1) | (12) | (4) | 31346 | 31329 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on divestitures | (1809) |  |  |  | (1809) |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on extinguishment and modification of debt |  |  |  | 389 | 389 |

---

__________

(1)&nbsp;&nbsp;&nbsp;&nbsp;During the three months ended September 30, 2024, commission revenue for the IAS, UCTS and MIS operating groups included direct bill revenue of $79.3 million, $1.5 million and $61.5 million, respectively, and agency bill revenue of $44.2 million, $105.0 million and $0.5 million, respectively.

(2)&nbsp;&nbsp;&nbsp;&nbsp;During the three months ended September 30, 2024, the UCTS operating group recorded commission revenue shared with other operating groups of $21.5 million and the MIS operating group recorded commission revenue shared within the same operating group of $0.2 million. Commission revenue shared with other operating groups or within the same operating group, and the related outside commissions, are eliminated through Corporate and Other.

(3)&nbsp;&nbsp;&nbsp;&nbsp;All other expenses, net include change in fair value of contingent consideration, gain (loss) on divestitures, other income (expense), net and income tax expense.

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **For the Nine Months Ended September 30, 2025** | **For the Nine Months Ended September 30, 2025** | **For the Nine Months Ended September 30, 2025** | **For the Nine Months Ended September 30, 2025** | **For the Nine Months Ended September 30, 2025** |
| **(in thousands)** | **Insurance Advisory Solutions** | **Underwriting, Capacity & <br>Technology Solutions** | **Mainstreet Insurance Solutions** | **Corporate<br>and Other** | **Total** |
| &nbsp;&nbsp;&nbsp;Revenues: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Commission revenue<sup>(1)(2)</sup> | $446886 | $324269 | $198362 | $(53973) | $915544 |
| &nbsp;&nbsp;&nbsp;&nbsp;Profit-sharing revenue | 42736 | 12589 | 17694 |  | 73019 |
| &nbsp;&nbsp;&nbsp;&nbsp;Consulting and service fee revenue | 69924 | 4526 |  |  | 74450 |
| &nbsp;&nbsp;&nbsp;&nbsp;Policy fee and installment fee revenue |  | 58263 |  |  | 58263 |
| &nbsp;&nbsp;&nbsp;&nbsp;Assumed premium earned |  | 15668 |  |  | 15668 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income | 6596 | 1122 | 4692 | (257) | 12153 |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment income | 3316 | 3514 | 161 | 1517 | 8508 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | 569458 | 419951 | 220909 | (52713) | 1157605 |
| Expenses: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Inside advisor commissions | 136890 | 506 | 23832 |  | 161228 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed compensation | 164089 | 46306 | 30046 | 7995 | 248436 |
| &nbsp;&nbsp;&nbsp;&nbsp;Benefits and other | 67428 | 26345 | 19155 | 9492 | 122420 |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation | 19193 | 10775 | 4860 | 16944 | 51772 |
| &nbsp;&nbsp;&nbsp;&nbsp;Severance | 1805 | 1898 | 502 | 240 | 4445 |
| &nbsp;&nbsp;&nbsp;&nbsp;Colleague earnout incentives | (1671) | (108) |  |  | (1779) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Colleague compensation and benefits | 387734 | 85722 | 78395 | 34671 | 586522 |
| &nbsp;&nbsp;&nbsp;&nbsp;Outside commissions<sup>(2)</sup> | 8589 | 207371 | 56790 | (54230) | 218520 |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling expense | 18238 | 4667 | 11223 | 6646 | 40774 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating expense | 42372 | 45268 | 17423 | 22215 | 127278 |
| &nbsp;&nbsp;&nbsp;&nbsp;Administrative expense | 41739 | 16055 | 26561 | 103011 | 187366 |
| &nbsp;&nbsp;&nbsp;&nbsp;All other expenses (income), net<sup>(3)</sup> | 6368 | (474) | 898 | 833 | 7625 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total expense | 505040 | 358609 | 191290 | 113146 | 1168085 |
| Net income (loss) | $64418 | $61342 | $29619 | $(165859) | $(10480) |
| Other segment disclosures: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of contingent consideration | $8203 | $(398) | $279 | $— | $8084 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization expense | 41014 | 15324 | 26316 | 4506 | 87160 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense (income), net | (1) | 319 | 50 | 92060 | 92428 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss (gain) on divestitures | (1901) |  |  | 1611 | (290) |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on extinguishment and modification of debt |  |  |  | 5684 | 5684 |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures | 4652 | 11752 | 8300 | 4470 | 29174 |
|  | **At September 30, 2025** | **At September 30, 2025** | **At September 30, 2025** | **At September 30, 2025** | **At September 30, 2025** |
| Total assets | $2238683 | $755322 | $724726 | $75043 | $3793774 |

---

__________

(1)&nbsp;&nbsp;&nbsp;&nbsp;During the nine months ended September 30, 2025, commission revenue for the IAS, UCTS and MIS operating groups included direct bill revenue of $281.5 million, $8.9 million and $196.7 million, respectively, and agency bill revenue of $165.4 million, $315.3 million and $1.6 million, respectively.

(2)&nbsp;&nbsp;&nbsp;&nbsp;During the nine months ended September 30, 2025, the IAS operating group recorded commission revenue shared with other operating groups of $0.3 million and the UCTS operating group recorded commission revenue shared with other operating groups of $54.0 million. Commission revenue shared with other operating groups, and the related outside commissions, are eliminated through Corporate and Other.

(3)&nbsp;&nbsp;&nbsp;&nbsp;All other expenses, net include change in fair value of contingent consideration, gain (loss) on divestitures, other income (expense), net and income tax expense.

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **For the Nine Months Ended September 30, 2024** | **For the Nine Months Ended September 30, 2024** | **For the Nine Months Ended September 30, 2024** | **For the Nine Months Ended September 30, 2024** | **For the Nine Months Ended September 30, 2024** |
| **(in thousands)** | **Insurance Advisory Solutions** | **Underwriting, Capacity & <br>Technology Solutions** | **Mainstreet Insurance Solutions** | **Corporate<br>and Other** | **Total** |
| &nbsp;&nbsp;&nbsp;Revenues: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Commission revenue<sup>(1)(2)</sup> | $442347 | $295503 | $192971 | $(57770) | $873051 |
| &nbsp;&nbsp;&nbsp;&nbsp;Profit-sharing revenue | 46508 | 8887 | 14362 |  | 69757 |
| &nbsp;&nbsp;&nbsp;&nbsp;Consulting and service fee revenue | 53214 | 4797 |  |  | 58011 |
| &nbsp;&nbsp;&nbsp;&nbsp;Policy fee and installment fee revenue |  | 43252 |  |  | 43252 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income | 3315 | 934 | 2089 |  | 6338 |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment income | 4426 | 2803 |  | 1507 | 8736 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | 549810 | 356176 | 209422 | (56263) | 1059145 |
| Expenses: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Inside advisor commissions | 128046 | 1239 | 21965 |  | 151250 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed compensation | 153427 | 39324 | 28687 | 3868 | 225306 |
| &nbsp;&nbsp;&nbsp;&nbsp;Benefits and other | 63005 | 25104 | 17047 | 6623 | 111779 |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation | 17839 | 6969 | 5370 | 16586 | 46764 |
| &nbsp;&nbsp;&nbsp;&nbsp;Severance | 1799 | 524 | 449 | 782 | 3554 |
| &nbsp;&nbsp;&nbsp;&nbsp;Colleague earnout incentives | 10706 |  |  |  | 10706 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Colleague compensation and benefits | 374822 | 73160 | 73518 | 27859 | 549359 |
| &nbsp;&nbsp;&nbsp;&nbsp;Outside commissions<sup>(2)</sup> | 8264 | 195658 | 58085 | (57770) | 204237 |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling expense | 16489 | 3373 | 11227 | 4600 | 35689 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating expense | 41606 | 28850 | 14224 | 18169 | 102849 |
| &nbsp;&nbsp;&nbsp;&nbsp;Administrative expense | 48254 | 11320 | 19741 | 113276 | 192591 |
| &nbsp;&nbsp;&nbsp;&nbsp;All other expenses (income), net<sup>(3)</sup> | 4756 | (26655) | 266 | 2295 | (19338) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total expense | 494191 | 285706 | 177061 | 108429 | 1065387 |
| Net income (loss) | $55619 | $70470 | $32361 | $(164692) | $(6242) |
| Other segment disclosures: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of contingent consideration | $9709 | $7355 | $212 | $— | $17276 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization expense | 47181 | 11193 | 19473 | 3106 | 80953 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense (income), net | (4) | (38) | 15 | 94230 | 94203 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on divestitures | (3843) | (35110) |  |  | (38953) |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on extinguishment and modification of debt |  |  |  | 15068 | 15068 |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures | 4318 | 13953 | 7290 | 3336 | 28897 |
|  | **At December 31, 2024** | **At December 31, 2024** | **At December 31, 2024** | **At December 31, 2024** | **At December 31, 2024** |
| Total assets | $2329152 | $621407 | $524576 | $59596 | $3534731 |

---

__________

(1)&nbsp;&nbsp;&nbsp;&nbsp;During the nine months ended September 30, 2024, commission revenue for the IAS, UCTS and MIS operating groups included direct bill revenue of $283.0 million, $5.2 million and $191.4 million, respectively, and agency bill revenue of $159.4 million, $290.4 million and $1.6 million, respectively.

(2)&nbsp;&nbsp;&nbsp;&nbsp;During the nine months ended September 30, 2024, the UCTS operating group recorded commission revenue shared with other operating groups of $56.6 million and the MIS operating group recorded commission revenue shared within the same operating group of $1.2 million. Commission revenue shared with other operating groups or within the same operating group, and the related outside commissions, are eliminated through Corporate and Other.

(3)&nbsp;&nbsp;&nbsp;&nbsp;All other expenses, net include change in fair value of contingent consideration, gain on divestitures, other income (expense), net and income tax expense.

------

**18. Captive Insurance Operations**

Effective January 1, 2025, the MSI Cell was licensed and participates as a quota share reinsurer on two of MSI's multifamily programs, renters and master tenant legal liability, for the purpose of further participating in underwriting results. The reinsurance quota share contract features an adjustment to assumed premium based on the loss ratio performance of the business ceded.

As of September 30, 2025, assumed premium written was $15.4 million and is included as a component of assumed premiums, commissions and fees receivable, net on the condensed consolidated balance sheet and accounted for as a funds withheld receivable, net of actual claims paid. As of September 30, 2025, assumed premiums unearned was $2.8 million and is included as a component of accrued expenses and other current liabilities on the condensed consolidated balance sheet.

For the three and nine months ended September 30, 2025, assumed premium earned was $5.9 million and $15.7 million, respectively, and is included in commissions and fees in the condensed consolidated statements of comprehensive loss. Changes in estimates, or differences between estimates and amounts ultimately paid, are reflected in the operating results of the period during which such adjustments are made. No such adjustments were made during the nine months ended September 30, 2025.

The table below provides a rollforward of unpaid losses and loss adjustment reserve:

---

| | |
|:---|:---|
| **(in thousands)** | **For the Nine Months Ended September 30, 2025** |
| Balance at beginning of period | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;Incurred losses and LAE | 13915 |
| &nbsp;&nbsp;&nbsp;&nbsp;Actual claims paid | (3082) |
| Balance at end of period | $10833 |

---

In December 2024, the initial funding to capitalize the Captive was $12.1 million, provided by Baldwin Holdings substantially in the form of a letter of credit. During August 2025, the Tennessee Department of Commerce and Insurance accepted an amendment to the letter of credit, which reduced funding for the Captive to $8.1 million. The Captive maintains capital of $8.0 million in excess of the minimum statutory amount required by regulatory authorities. The statutory capital and surplus of the Captive was $8.7 million as of September 30, 2025, as allowed by prescribed practices by the Tennessee Department of Commerce and Insurance.

------

**ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS**

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the related notes and other financial information included elsewhere in this Quarterly Report on Form 10-Q and in our Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on February 25, 2025. In addition to historical consolidated financial information, the following discussion contains forward-looking statements that reflect our plans, estimates, and beliefs. Our actual results may differ materially from those discussed in the forward-looking statements as a result of various factors, including those set forth in Part I, Item 1A. Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2024.

**THE COMPANY**

The Baldwin Insurance Group, Inc. is a holding company and sole managing member of The Baldwin Insurance Group Holdings, LLC (formerly Baldwin Risk Partners, LLC) ("Baldwin Holdings") and its sole material asset is its ownership interest in Baldwin Holdings, through which all of our business has been and is conducted. In this Quarterly Report on Form 10-Q, unless the context otherwise requires, the words "Baldwin," the "Company," "we," "us" and "our" refer to The Baldwin Insurance Group, Inc., together with its consolidated subsidiaries, including Baldwin Holdings and its consolidated subsidiaries and affiliates.

We represent over three million clients across the United States and internationally. Our 4,000 plus colleagues include approximately 700 risk advisors, who are fiercely independent, relentlessly competitive and "insurance geeks." We have approximately 110 offices in 23 states, all of which are equipped to provide diversified products and services to empower our clients at every stage through our three operating groups.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**• Insurance Advisory Solutions** ("IAS") provides expertly-designed commercial risk management, employee benefits and private risk management solutions for businesses and high-net-worth individuals, as well as their families. Risk management solutions typically involve the sale of a wide variety of both commercial and personal lines insurance products that mitigate risks for firms and individuals. Employee benefits solutions can include health plans, dental plans, and retirement accounts for firms and their employees. We are privileged to have partnered with some of the highest quality independent insurance brokers across the country with vast and varied strategic capabilities and expertise. We have been intentional in recognizing and elevating this talent across the organization to build world class industry-focused practice groups and product Centers of Excellence that can be leveraged by the entire firm.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Underwriting, Capacity & Technology Solutions** ("UCTS") consists of three distinct divisions—MSI, our Capacity Solutions group (which includes our reinsurance brokerage business, Juniper Re, our reinsurance MGA business, MultiStrat, and our captive management business), and the Captive business. Through MSI, we manufacture proprietary, technology-enabled insurance products that are then distributed (in many instances via technology and/or API integrations) internally via our risk advisors across our other operating groups and externally via select distribution partners, with a focus on sheltered channels where our products deliver speed, ease of use and certainty of execution, an example of which is the national embedded renters insurance product sold at point of lease via integrations with property management software providers. As a prominent growth driver for the Company, we have invested heavily in the expansion of our MGA product suite, which is now comprised of more than 20 products across commercial, personal and professional lines. In 2024, we made significant investment in the development of new middle-market oriented commercial lines products, two of which have gone live in the first half of 2025. UCTS' Wholesale Business was sold in the first quarter of 2024, and its operations are included in our results through the end of February 2024.

------

In January 2025, we received final approval and a Certificate of Authority from the Texas Department of Insurance to form a Texas-domiciled reciprocal insurance exchange (the "Reciprocal"), for which we serve as the Attorney-in-Fact (the "AIF"). The third-party led capitalization of the Reciprocal closed and funded in full on May 6, 2025, and we began writing business into the Reciprocal late in the second quarter of 2025. Based on the structure of the Reciprocal, we do not consolidate the Reciprocal's financial results, and the AIF entity is treated as an equity method investment in UCTS.

UCTS includes TBG Assurance Company, LLC, a wholly-owned protected cell captive insurance company ("PCC") domiciled in Tennessee, which was established to allow Baldwin to further participate in the underwriting results of a small portion of its MGA programs. The PCC allows for the creation of multiple independent cells (series) within a single legal entity, TBG Assurance Company, LLC (the "Core"). The initial series, MSI Multifamily Series Protected Cell (the "MSI Cell" and, collectively with the Core, the "Captive") became effective January 1, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Mainstreet Insurance Solutions** ("MIS") offers personal insurance, commercial insurance and life and health solutions to individuals and businesses in their communities, with a focus on accessing clients via sheltered distribution channels, which include, but are not limited to, new home builders, realtors, mortgage originators/lenders, master planned communities, and various other community centers of influence. We have invested deeply in talent, technology and capabilities across MIS, including in Westwood's homeowners solutions that are embedded in many of the top home builders in the United States, the national expansion of our distribution footprint through our National Mortgage and Real Estate Center, and enhanced digital capabilities focused on improving the advisor and client experience. Mainstreet Insurance Solutions also offers consultation for government assistance programs and solutions, including traditional Medicare, Medicare Advantage and Affordable Care Act, to seniors and eligible individuals through a network of primarily independent contractor agents.

**Seasonality**

The insurance brokerage market is seasonal and our results of operations are somewhat affected by seasonal trends. Our adjusted EBITDA and adjusted EBITDA margin are typically highest in the first quarter and lowest in the fourth quarter. This variation is primarily due to fluctuations in our revenues, while overhead remains consistent throughout the year. Our revenues are generally highest in the first quarter due to a higher degree of first quarter policy commencements and renewals in certain Insurance Advisory Solutions and Mainstreet Insurance Solutions lines of business such as employee benefits, commercial and Medicare. In addition, a higher proportion of our first quarter revenue is derived from our highest margin businesses.

Partnerships can significantly impact adjusted EBITDA and adjusted EBITDA margin in a given year and may increase the amount of seasonality within the business, especially results attributable to partnerships that have not been fully integrated into our business or owned by us for a full year.

**RESULTS OF OPERATIONS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2025 AND 2024** 

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements for the three and nine months ended September 30, 2025 and 2024 and the related notes and other financial information included elsewhere in this report.

In addition to historical financial information, the following discussion and analysis contains forward-looking statements that involve risks, uncertainties and assumptions. Our actual results and timing of selected events may differ materially from those anticipated in these forward-looking statements as a result of many factors, including those discussed under Part I, Item 1A. Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2024.

------

The following is a discussion of our consolidated results of operations for the three and nine months ended September 30, 2025 and 2024.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **For the Three Months<br> Ended September 30,** | **For the Three Months<br> Ended September 30,** | **Variance** | **Variance** | **For the Nine Months<br> Ended September 30,** | **For the Nine Months<br> Ended September 30,** | **Variance** | **Variance** |
| **(in thousands)** | **2025** | **2024** | **Amount** | **%** | **2025** | **2024** | **Amount** | **%** |
| Revenues: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Core commissions and fees | $330820 | $305530 | $25290 | 8% | $1063925 | $974314 | $89611 | 9% |
| &nbsp;&nbsp;&nbsp;&nbsp;Profit-sharing and other income | 31497 | 29680 | 1817 | 6% | 85172 | 76095 | 9077 | 12% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commissions and fees | 362317 | 335210 | 27107 | 8% | 1149097 | 1050409 | 98688 | 9% |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment income | 3072 | 3728 | (656) | (18)% | 8508 | 8736 | (228) | (3)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | 365389 | 338938 | 26451 | 8% | 1157605 | 1059145 | 98460 | 9% |
| Operating expenses: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Colleague compensation and benefits | 193031 | 172645 | 20386 | 12% | 586522 | 549359 | 37163 | 7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Outside commissions | 79111 | 74544 | 4567 | 6% | 218520 | 204237 | 14283 | 7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other operating expenses | 56008 | 48839 | 7169 | 15% | 170146 | 141198 | 28948 | 21% |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization expense | 30394 | 26899 | 3495 | 13% | 82286 | 76334 | 5952 | 8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of contingent consideration | 1980 | (952) | 2932 | n/m | 8084 | 17276 | (9192) | (53)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation expense | 1649 | 1557 | 92 | 6% | 4874 | 4619 | 255 | 6% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 362173 | 323532 | 38641 | 12% | 1070432 | 993023 | 77409 | 8% |
| Operating income | 3216 | 15406 | (12190) | (79)% | 87173 | 66122 | 21051 | 32% |
| Other income (expense): |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense, net | (31132) | (31329) | 197 | (1)% | (92428) | (94203) | 1775 | (2)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on divestitures |  | 1809 | (1809) | (100)% | 290 | 38953 | (38663) | (99)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on extinguishment and modification of debt | (3290) | (389) | (2901) | n/m | (5684) | (15068) | 9384 | (62)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income, net | 860 | 28 | 832 | n/m | 745 | 105 | 640 | n/m |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other expense, net | (33562) | (29881) | (3681) | 12% | (97077) | (70213) | (26864) | 38% |
| Loss before income taxes and share of net earnings of equity method investment | $(30346) | $(14475) | $(15871) | 110% | $(9904) | $(4091) | $(5813) | 142% |

---

__________

n/m&nbsp;&nbsp;&nbsp;&nbsp;not meaningful

**Commissions and Fees**

We earn commissions and fees by facilitating the arrangement between insurance company and reinsurance company partners and clients for the insurance and/or reinsurance company to provide insurance and/or reinsurance to the insured party. Our commissions are usually a percentage of the premium paid by the insured and generally depend on the type of insurance, the particular insurance or reinsurance company partner and the nature of the services provided. Under certain arrangements with clients, we earn pre-negotiated service fees for insurance placement services. Additionally, we earn policy fees for acting in the capacity of an MGA and fulfilling certain administrative functions on behalf of insurance or reinsurance company partners, including delivery of policy documents, processing payments and other administrative functions, and the Captive business earns revenue from assumed premium. We may also receive profit-sharing commissions, which represent forms of variable consideration paid by insurance company partners and reinsurance company partners associated with the placement of coverage. Profit-sharing commissions are generally based on underwriting results, but may also contain considerations for volume, growth or retention. Other revenue streams include other ancillary income, premium financing income, and marketing income based on negotiated cost reimbursement for fulfilling specific targeted Medicare marketing campaigns.

------

Commissions and fees increased $27.1 million, or 8%, for the quarter ended September 30, 2025 compared to the same period of 2024, driven by organic growth in core commissions and fees of $13.7 million related to continued outperformance from MSI, commissions and fees contributed by partnership activity of $12.2 million, and organic growth in profit-sharing and other revenue of $1.5 million.

Commissions and fees increased $98.7 million, or 9%, for the year-to-date period ended September 30, 2025 compared to the same period of 2024, driven by organic growth in core commissions and fees of $82.6 million related to new and renewal business across client industry sectors and continued outperformance from MSI, commissions and fees contributed by partnership activity of $14.2 million, and organic growth in profit-sharing and other revenue of $8.8 million, which is largely the result of improvements in loss ratios and the number of policies sold in MIS. This growth was offset in part by a decrease in core commissions and fees of $5.5 million related to the divestiture of our Wholesale Business in the first quarter of 2024. Core commissions and fees growth, excluding revenue related to the Wholesale Business during 2024, was 10%.

**Colleague Compensation and Benefits**

Colleague compensation and benefits is our largest expense. It consists of (i) base compensation comprising salary, bonuses and benefits paid and payable to colleagues, and commissions paid to colleagues, and (ii) equity-based compensation associated with the grants of restricted and unrestricted stock awards to senior management, colleagues, risk advisors and directors. We expect to continue to experience a general rise in colleague compensation and benefits expense commensurate with expected revenue growth as our compensation arrangements with our colleagues and risk advisors contain significant bonus or commission components driven by the results of our operations. In addition, we operate in competitive markets for human capital and need to maintain competitive compensation levels as we expand geographically and create new products and services.

Colleague compensation and benefits expense increased $20.4 million, or 12%, for the quarter ended September 30, 2025 compared to the same period of 2024. Partnership activity contributed $3.1 million to the increase in colleague compensation and benefits during the third quarter of 2025. After excluding colleague compensation and benefits expense related to partnership activity, colleague compensation and benefits increased $17.3 million, primarily resulting from the overall growth of the business.

Colleague compensation and benefits expense increased $37.2 million, or 7%, for the year-to-date period ended September 30, 2025 compared to the same period of 2024. Partnership activity contributed $4.5 million to the increase in colleague compensation and benefits year-to-date in 2025, offset in part by a $1.4 million decrease related to our Wholesale Business, which was sold in the first quarter of 2024. After excluding colleague compensation and benefits expense related to our partnerships and divestitures, colleague compensation and benefits increased $34.0 million, primarily resulting from the overall growth of the business.

**Outside Commissions**

Outside commissions increased $4.6 million, or 6%, for the quarter ended September 30, 2025 compared to the same period of 2024. Outside commissions increased at a lower rate than core commissions and fees primarily due to continued scaling of our UCTS business, product mix shift and contributions from the Capacity Solutions group (which generally does not have significant outside commissions).

Outside commissions increased $14.3 million, or 7%, for the year-to-date period ended September 30, 2025 compared to the same period of 2024. After excluding outside commissions of $3.0 million earned by the Wholesale Business during 2024 for which there was no comparable expense in 2025, outside commissions increased $17.3 million, or 9%, which was in line with core commissions and fees.

**Other Operating Expense**

Other operating expenses include travel, accounting, legal and other professional fees, placement fees, rent, office expenses and other costs associated with our operations. Our occupancy-related costs and professional services expenses, in particular, generally increase or decrease in relative proportion to the number of our colleagues and the overall size and scale of our business operations.

Other operating expenses increased $7.2 million for the quarter ended September 30, 2025 compared to the same period of 2024, driven by higher incurred losses and LAE of $5.1 million related to our newly-established Captive business and professional fees of $1.4 million due to increased legal spend.

------

Other operating expenses increased $28.9 million for the year-to-date period ended September 30, 2025 compared to the same period of 2024 driven by higher incurred losses and LAE of $14.0 million related to our newly-established Captive business, professional fees of $6.9 million due to increased legal spend, which includes fees related to the setup of the Reciprocal, advertising and marketing of $3.7 million in connection with the continued rollout of our rebranding, technology and software-related costs of $2.5 million, and licenses and taxes of $1.8 million due to growth in the business.

**Amortization Expense**

Amortization expense increased $3.5 million and $6.0 million for the quarter and year-to-date periods ended September 30, 2025 compared to the same periods of 2024, respectively, driven by our partnership activity and an increase in capitalized software.

**Change in Fair Value of Contingent Consideration**

The change in fair value of contingent consideration was a $2.0 million loss for the quarter ended September 30, 2025 compared to a $1.0 million gain for the same period of 2024, and a $8.1 million loss for the year-to-date period ended September 30, 2025 compared to a $17.3 million loss for the same period of 2024. The fair value loss related to contingent consideration for the third quarter of 2025 was impacted by positive changes in revenue growth trends of certain partners. The fair value loss related to contingent consideration for the year-to-date period of 2025 was impacted by positive changes in revenue growth trends of certain partners and accretion of the contingent earnout obligations approaching their respective measurement dates, in addition to a loss recognized in reclassifying $1.8 million of earnouts from colleague compensation and benefits.

**Interest Expense, Net**

Interest expense, net, was relatively flat for the third quarter of 2025 compared to the same period of 2024 resulting from a lower average interest rate due to the 2025 Refinancings, offset by higher average borrowings.

Interest expense, net, decreased $1.8 million for the year-to-date period ended September 30, 2025 compared to the same period of 2024 resulting from a lower average interest rate due to the 2025 Refinancings, offset in part by higher average borrowings. We expect interest expense to remain relatively flat in the near term on a year-over-year basis due to higher borrowings under our Revolving Facility to fund the settlement of deferred payment obligations and certain partnership opportunities, offset by lower expected average interest rates.

**Gain on Divestitures**

Gain on divestitures decreased $38.7 million for the year-to-date period ended September 30, 2025 compared to the same period of 2024, driven by a $35.1 million gain recorded during 2024 in connection with the sale of our Wholesale Business.

**Loss on Extinguishment and Modification of Debt** 

Loss on extinguishment and modification of debt of $3.3 million for the quarter ended September 30, 2025 relates to the September 2025 Refinancing.

Loss on extinguishment and modification of debt of $5.7 million for the year-to-date period ended September 30, 2025 relates to the 2025 Refinancings. Loss on extinguishment and modification of debt of $15.1 million for the year-to-date period ended September 30, 2024 relates to a debt refinancing completed in May 2024.

**NON-GAAP FINANCIAL MEASURES**

Adjusted EBITDA, adjusted EBITDA margin, organic revenue, organic revenue growth, adjusted net income and adjusted diluted earnings per share ("EPS"), are not measures of financial performance under GAAP and should not be considered substitutes for GAAP measures, including commissions and fees (for organic revenue and organic revenue growth), net income (loss) (for adjusted EBITDA and adjusted EBITDA margin), net income (loss) attributable to Baldwin (for adjusted net income) or diluted earnings (loss) per share (for adjusted diluted EPS), which we consider to be the most directly comparable GAAP measures. These non-GAAP financial measures have limitations as analytical tools, and when assessing our operating performance, you should not consider these non-GAAP financial measures in isolation or as substitutes for commissions and fees, net income (loss), net income (loss) attributable to Baldwin, diluted earnings (loss) per share or other consolidated income statement data prepared in accordance with GAAP. Other companies in our industry may define or calculate these non-GAAP financial measures differently than we do, and accordingly, these measures may not be comparable to similarly titled measures used by other companies.

------

We define adjusted EBITDA as net income (loss) before interest, taxes, depreciation, amortization, change in fair value of contingent consideration and certain items of income and expense, including share-based compensation expense, transaction-related partnership and integration expenses, severance, and certain non-recurring items, including those related to raising capital. We believe that adjusted EBITDA is an appropriate measure of operating performance because it eliminates the impact of income and expenses that do not relate to business performance, and that the presentation of this measure enhances an investor's understanding of our financial performance.

Adjusted EBITDA margin is calculated as adjusted EBITDA divided by total revenue. Adjusted EBITDA margin is a key metric used by management and our board of directors to assess our financial performance. We believe that adjusted EBITDA margin is an appropriate measure of operating performance because it eliminates the impact of income and expenses that do not relate to business performance, and that the presentation of this measure enhances an investor's understanding of our financial performance. We believe that adjusted EBITDA margin is helpful in measuring profitability of operations on a consolidated level.

Adjusted EBITDA and adjusted EBITDA margin have important limitations as analytical tools. For example, adjusted EBITDA and adjusted EBITDA margin:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• do not reflect any cash capital expenditure requirements for the assets being depreciated and amortized that may have to be replaced in the future;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• do not reflect changes in, or cash requirements for, our working capital needs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• do not reflect the impact of certain cash charges resulting from matters we consider not to be indicative of our ongoing operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• do not reflect the interest expense or the cash requirements necessary to service interest or principal payments on our debt;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• do not reflect share-based compensation expense and other non-cash charges; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• exclude certain tax payments that may represent a reduction in cash available to us.

We calculate organic revenue based on commissions and fees for the relevant period by excluding (i) the first twelve months of commissions and fees generated from new partners and (ii) commissions and fees from divestitures. Organic revenue growth is the change in organic revenue period-to-period, with prior period results adjusted to (i) include commissions and fees that were excluded from organic revenue in the prior period because the relevant partners had not yet reached the twelve-month owned mark, but which have reached the twelve-month owned mark in the current period, and (ii) exclude commissions and fees related to divestitures from organic revenue. For example, commissions and fees from a partner acquired on June 1, 2024 are excluded from organic revenue for 2024. However, after June 1, 2025, results from June 1, 2024 to December 31, 2024 for such partners are compared to results from June 1, 2025 to December 31, 2025 for purposes of calculating organic revenue growth in 2025. Organic revenue growth is a key metric used by management and our board of directors to assess our financial performance. We believe that organic revenue and organic revenue growth are appropriate measures of operating performance as they allow investors to measure, analyze and compare growth in a meaningful and consistent manner.

We define adjusted net income as net income (loss) attributable to Baldwin adjusted for depreciation, amortization, change in fair value of contingent consideration and certain items of income and expense, including share-based compensation expense, transaction-related partnership and integration expenses, severance, and certain non-recurring costs that, in the opinion of management, significantly affect the period-over-period assessment of operating results, and the related tax effect of those adjustments. We believe that adjusted net income is an appropriate measure of operating performance because it eliminates the impact of income and expenses that do not relate to business performance.

Adjusted diluted EPS measures our per share earnings excluding certain expenses as discussed above for adjusted net income and assuming all shares of Class B common stock were exchanged for Class A common stock on a one-for-one basis. Adjusted diluted EPS is calculated as adjusted net income divided by adjusted diluted weighted-average shares outstanding. We believe adjusted diluted EPS is useful to investors because it enables them to better evaluate per share operating performance across reporting periods.

------

**Adjusted EBITDA and Adjusted EBITDA Margin**

The following table reconciles adjusted EBITDA and adjusted EBITDA margin to net loss, which we consider to be the most directly comparable GAAP financial measure:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For the Three Months<br> Ended September 30,** | **For the Three Months<br> Ended September 30,** | **For the Nine Months<br> Ended September 30,** | **For the Nine Months<br> Ended September 30,** |
| **(in thousands, except percentages)** | **2025** | **2024** | **2025** | **2024** |
| Revenues | $365389 | $338938 | $1157605 | $1059145 |
| Net loss | $(30237) | $(14475) | $(10480) | $(6242) |
| Adjustments to net loss: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest expense, net | 31971 | 31329 | 93267 | 94203 |
| &nbsp;&nbsp;&nbsp;Amortization expense | 30394 | 26899 | 82286 | 76334 |
| &nbsp;&nbsp;&nbsp;Share-based compensation | 22017 | 17949 | 51772 | 46764 |
| &nbsp;&nbsp;&nbsp;Change in fair value of contingent consideration | 1980 | (952) | 8084 | 17276 |
| &nbsp;&nbsp;&nbsp;Transaction-related partnership and integration expenses | 2376 | 2047 | 7894 | 9042 |
| &nbsp;&nbsp;&nbsp;Loss on extinguishment and modification of debt | 3290 | 389 | 5684 | 15068 |
| &nbsp;&nbsp;&nbsp;Depreciation expense | 1649 | 1557 | 4874 | 4619 |
| &nbsp;&nbsp;&nbsp;Severance | 1620 | 678 | 4445 | 3554 |
| &nbsp;&nbsp;&nbsp;Income and other taxes<sup>(1)</sup> | 470 | 82 | 3289 | 3300 |
| &nbsp;&nbsp;&nbsp;Transformation costs | 3638 |  | 4410 |  |
| &nbsp;&nbsp;&nbsp;Colleague earnout incentives |  | 4327 | (1779) | 10706 |
| &nbsp;&nbsp;&nbsp;Impairment of right-of-use assets | 66 |  | 1254 |  |
| &nbsp;&nbsp;&nbsp;Gain on divestitures |  | (1809) | (290) | (38953) |
| &nbsp;&nbsp;&nbsp;Loss on interest rate caps |  | 84 | 18 | 244 |
| &nbsp;&nbsp;&nbsp;Other<sup>(2)</sup> | 3286 | 4646 | 17099 | 13410 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted EBITDA | $72520 | $72751 | $271827 | $249325 |
| Net loss margin | (8)% | (4)% | (1)% | (1)% |
| Adjusted EBITDA margin | 20% | 21% | 23% | 24% |

---

__________

(1)&nbsp;&nbsp;&nbsp;&nbsp;Income and other taxes include the Tax Receivable Agreement expense and other operating tax expense, such as state taxes, under GAAP.

(2)&nbsp;&nbsp;&nbsp;&nbsp;Other addbacks to adjusted EBITDA include certain income and expenses that are considered to be non-recurring or non-operational, including certain recruiting costs, professional fees, litigation costs and bonuses.

**Organic Revenue and Organic Revenue Growth**

The following table reconciles organic revenue and organic revenue growth to commissions and fees, which we consider to be the most directly comparable GAAP financial measure:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For the Three Months<br> Ended September 30,** | **For the Three Months<br> Ended September 30,** | **For the Nine Months<br> Ended September 30,** | **For the Nine Months<br> Ended September 30,** |
| **(in thousands, except percentages)** | **2025** | **2024** | **2025** | **2024** |
| Commissions and fees | $362317 | $335210 | $1149097 | $1050409 |
| Partnership commissions and fees<sup>(1)</sup> | (12222) |  | (14202) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Organic revenue | $350095 | $335210 | $1134895 | $1050409 |
| Organic revenue growth<sup>(2)</sup> | $15177 | $40672 | $91369 | $144844 |
| Organic revenue growth %<sup>(2)</sup> | 5% | 14% | 9% | 16% |

---

__________

(1)&nbsp;&nbsp;&nbsp;&nbsp;Includes the first twelve months of such commissions and fees generated from newly acquired partners.

(2)&nbsp;&nbsp;&nbsp;&nbsp;Organic revenue for the three and nine months ended September 30, 2024 used to calculate organic revenue growth for the three and nine months ended September 30, 2025 was $334.9 million and $1.044 billion, respectively, which is adjusted to exclude commissions and fees from divestitures that occurred during 2025 and 2024.

------

**Adjusted Net Income and Adjusted Diluted EPS**

The following table reconciles adjusted net income to net loss attributable to Baldwin and reconciles adjusted diluted EPS to diluted loss per share, which we consider to be the most directly comparable GAAP financial measures:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For the Three Months<br> Ended September 30,** | **For the Three Months<br> Ended September 30,** | **For the Nine Months<br> Ended September 30,** | **For the Nine Months<br> Ended September 30,** |
| **(in thousands, except per share data)** | **2025** | **2024** | **2025** | **2024** |
| Net loss attributable to Baldwin | $(18727) | $(8377) | $(7952) | $(4356) |
| &nbsp;&nbsp;&nbsp;Net loss attributable to noncontrolling interests | (11510) | (6098) | (2528) | (1886) |
| &nbsp;&nbsp;&nbsp;Amortization expense | 30394 | 26899 | 82286 | 76334 |
| &nbsp;&nbsp;&nbsp;Share-based compensation | 22017 | 17949 | 51772 | 46764 |
| &nbsp;&nbsp;&nbsp;Change in fair value of contingent consideration | 1980 | (952) | 8084 | 17276 |
| &nbsp;&nbsp;&nbsp;Transaction-related partnership and integration expenses | 2376 | 2047 | 7894 | 9042 |
| &nbsp;&nbsp;&nbsp;Loss on extinguishment and modification of debt | 3290 | 389 | 5684 | 15068 |
| &nbsp;&nbsp;&nbsp;Depreciation | 1649 | 1557 | 4874 | 4619 |
| &nbsp;&nbsp;&nbsp;Severance | 1620 | 678 | 4445 | 3554 |
| &nbsp;&nbsp;&nbsp;Other amortization/accretion, net | 486 | 1422 | 3329 | 4419 |
| &nbsp;&nbsp;&nbsp;Transformation costs | 3638 |  | 4410 |  |
| &nbsp;&nbsp;&nbsp;Income tax expense<sup>(1)</sup> |  |  | 1885 | 2151 |
| &nbsp;&nbsp;&nbsp;Colleague earnout incentives |  | 4327 | (1779) | 10706 |
| &nbsp;&nbsp;&nbsp;Impairment of right-of-use assets | 66 |  | 1254 |  |
| &nbsp;&nbsp;&nbsp;Gain on divestitures |  | (1809) | (290) | (38953) |
| &nbsp;&nbsp;&nbsp;Loss on interest rate caps, net of cash settlements |  | 84 | 18 | 2544 |
| &nbsp;&nbsp;&nbsp;Other<sup>(2)</sup> | 3286 | 4646 | 17099 | 13410 |
| Adjusted pre-tax income | 40565 | 42762 | 180485 | 160692 |
| &nbsp;&nbsp;&nbsp;Adjusted income taxes<sup>(3)</sup> | 4016 | 4234 | 17868 | 15909 |
| Adjusted net income | $36549 | $38528 | $162617 | $144783 |
| Weighted-average shares of Class A common stock outstanding - diluted | 68605 | 64012 | 67572 | 63001 |
| &nbsp;&nbsp;&nbsp;Dilutive weighted-average shares of Class A common stock | 3265 | 4014 | 3320 | 3570 |
| &nbsp;&nbsp;&nbsp;Exchange of Class B common stock<sup>(4)</sup> | 47234 | 50490 | 47991 | 51234 |
| Adjusted diluted weighted-average shares outstanding | 119104 | 118516 | 118883 | 117805 |
| Diluted loss per share | $(0.27) | $(0.13) | $(0.12) | $(0.07) |
| &nbsp;&nbsp;&nbsp;Effect of exchange of Class B common stock and net loss attributable to noncontrolling interests per share | 0.02 | 0.01 | 0.03 | 0.02 |
| &nbsp;&nbsp;&nbsp;Other adjustments to loss per share | 0.59 | 0.49 | 1.61 | 1.42 |
| &nbsp;&nbsp;&nbsp;Adjusted income taxes per share | (0.03) | (0.04) | (0.15) | (0.14) |
| Adjusted diluted EPS | $0.31 | $0.33 | $1.37 | $1.23 |

---

___________

(1)&nbsp;&nbsp;&nbsp;&nbsp;Income tax expense includes the Tax Receivable Agreement expense.

(2)&nbsp;&nbsp;&nbsp;&nbsp;Other addbacks to adjusted net income include certain income and expenses that are considered to be non-recurring or non-operational, including certain recruiting costs, professional fees, litigation costs and bonuses.

(3)&nbsp;&nbsp;&nbsp;&nbsp;Represents corporate income taxes at an assumed effective tax rate of 9.9% applied to adjusted pre-tax income.

(4)&nbsp;&nbsp;&nbsp;&nbsp;Assumes the full exchange of Class B common stock for Class A common stock pursuant to the Amended LLC Agreement.

------

**INSURANCE ADVISORY SOLUTIONS OPERATING GROUP RESULTS**

IAS provides expertly-designed commercial risk management, employee benefits and private risk management solutions for businesses and high-net-worth individuals, as well as their families, through our national footprint, which has assimilated some of the highest quality independent insurance brokers in the country with vast and varied strategic capabilities and expertise.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **For the Three Months<br> Ended September 30,** | **For the Three Months<br> Ended September 30,** | **Variance** | **Variance** | **For the Nine Months<br> Ended September 30,** | **For the Nine Months<br> Ended September 30,** | **Variance** | **Variance** |
| **(in thousands, except percentages)** | **2025** | **2024** | **Amount** | **%** | **2025** | **2024** | **Amount** | **%** |
| Revenues: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Core commissions and fees | $142222 | $141169 | $1053 | 1% | $516810 | $495561 | $21249 | 4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Profit-sharing and other income | 14918 | 16366 | (1448) | (9)% | 49332 | 49823 | (491) | (1)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commissions and fees | 157140 | 157535 | (395) | —% | 566142 | 545384 | 20758 | 4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment income | 1380 | 1803 | (423) | (23)% | 3316 | 4426 | (1110) | (25)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | 158520 | 159338 | (818) | (1)% | 569458 | 549810 | 19648 | 4% |
| Operating expenses: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Colleague compensation and benefits | 123492 | 116715 | 6777 | 6% | 387734 | 374822 | 12912 | 3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Outside commissions | 2151 | 2551 | (400) | (16)% | 8589 | 8264 | 325 | 4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other operating expenses | 19281 | 20098 | (817) | (4)% | 61336 | 59328 | 2008 | 3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization expense | 13316 | 16435 | (3119) | (19)% | 40075 | 46087 | (6012) | (13)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of contingent consideration | 1533 | (4195) | 5728 | (137)% | 8203 | 9709 | (1506) | (16)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation expense | 313 | 363 | (50) | (14)% | 939 | 1094 | (155) | (14)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 160086 | 151967 | 8119 | 5% | 506876 | 499304 | 7572 | 2% |
| Operating income (loss) | (1566) | 7371 | (8937) | (121)% | 62582 | 50506 | 12076 | 24% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total other income, net | 1121 | 1828 | (707) | (39)% | 1852 | 5138 | (3286) | (64)% |
| Income (loss) before income taxes and share of net earnings of equity method investment | $(445) | $9199 | $(9644) | (105)% | $64434 | $55644 | $8790 | 16% |

---

**Commissions and Fees**

IAS generates (i) commissions for placing insurance policies on behalf of its insurance company partners; (ii) profit-sharing income based on either the underlying book of business or performance, such as loss ratios; and (iii) fees from consulting and service fee arrangements, which are in place with certain clients for a negotiated fee.

IAS commissions and fees decreased $0.4 million for the quarter ended September 30, 2025 compared to the same period of 2024, driven by a decrease in profit-sharing and other revenue, offset in part by an increase in core commissions and fees. Growth in our core commissions and fees was driven by 20% sales velocity (new business as a percentage of prior year commissions and fees) compared to 23% in the prior-year period. Organic growth was pressured by 570 bps of headwind in underlying rate and exposure during the quarter, attributable to softening insurance rates, as well as overall lower economic activity.

IAS commissions and fees increased $20.8 million for the year-to-date period ended September 30, 2025 compared to the same period of 2024, due primarily to organic growth in core commissions and fees. Growth in our core commissions and fees was driven by 19% sales velocity compared to 21% in the prior-year period. Organic growth was pressured by 170 bps of headwind in underlying rate and exposure change year over year, attributable to softening insurance rates, particularly in the property line of business, as well as overall lower economic activity.

------

**Colleague Compensation and Benefits**

Colleague compensation and benefits expense for IAS increased $6.8 million for the quarter ended September 30, 2025 compared to the same period of 2024, primarily due to increases in inside advisor commissions of $6.4 million and colleague compensation of $5.0 million, offset in part by a decrease in colleague earnout incentives of $4.3 million.

Colleague compensation and benefits expense for IAS increased $12.9 million for the year-to-date period ended September 30, 2025 compared to the same period of 2024, primarily due to increases in colleague compensation of $12.0 million, inside advisor commissions of $8.8 million and benefits and other of $4.4 million, partially offset by a decrease in colleague earnout incentives of $12.4 million.

**Other Operating Expenses**

Other operating expenses for IAS increased $2.0 million for the year-to-date period ended September 30, 2025 compared to the same period of 2024, due primarily to higher costs for professional fees of $3.0 million and advertising and marketing of $1.7 million, partially offset by lower legal settlement expense of $1.1 million.

**Amortization Expense**

Amortization expense for IAS decreased $3.1 million and $6.0 million for the quarter and year-to-date periods ended September 30, 2025 compared to the same periods of 2024, respectively, as a result of several trade names having reached the end of their useful lives over the past twelve months.

**Change in Fair Value of Contingent Consideration**

The change in fair value of contingent consideration for IAS was a $1.5 million loss for the quarter ended September 30, 2025 compared to a $4.2 million gain for the same period of 2024, and a $8.2 million loss for the year-to-date period ended September 30, 2025 compared to a $9.7 million loss for the same period of 2024. The fair value loss for the quarter ended September 30, 2025 was impacted by positive changes in revenue growth trends of certain partners. The fair value loss for the year-to-date period ended September 30, 2025 was impacted by positive changes in revenue growth trends of certain partners, in addition to a loss recognized in reclassifying $1.6 million of earnouts from colleague compensation and benefits.

------

**UNDERWRITING, CAPACITY & TECHNOLOGY SOLUTIONS OPERATING GROUP RESULTS**

UCTS consists of three distinct divisions—MSI, our Capacity Solutions group (which includes our reinsurance brokerage business, Juniper Re; our reinsurance MGA business, MultiStrat; and our captive management business), and the Captive business. Through MSI, we manufacture proprietary, technology-enabled insurance products with a focus on sheltered channels where our products deliver speed, ease of use and certainty of execution, an example of which is our national embedded renters insurance product sold at point of lease via integrations with property management software providers. Our MGA product suite is now comprised of more than 20 products across personal, commercial and professional lines. UCTS' Wholesale Business was sold in the first quarter of 2024, and its operations are included in our results through February 29, 2024.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **For the Three Months<br> Ended September 30,** | **For the Three Months<br> Ended September 30,** | **Variance** | **Variance** | **For the Nine Months<br> Ended September 30,** | **For the Nine Months<br> Ended September 30,** | **Variance** | **Variance** |
| **(in thousands, except percentages)** | **2025** | **2024** | **Amount** | **%** | **2025** | **2024** | **Amount** | **%** |
| Revenues: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Core commissions and fees | $140297 | $124079 | $16218 | 13% | $402726 | $343552 | $59174 | 17% |
| &nbsp;&nbsp;&nbsp;&nbsp;Profit-sharing and other income | 5629 | 4639 | 990 | 21% | 13711 | 9821 | 3890 | 40% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commissions and fees | 145926 | 128718 | 17208 | 13% | 416437 | 353373 | 63064 | 18% |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment income | 1341 | 1076 | 265 | 25% | 3514 | 2803 | 711 | 25% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | 147267 | 129794 | 17473 | 13% | 419951 | 356176 | 63775 | 18% |
| Operating expenses: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Colleague compensation and benefits | 30375 | 23617 | 6758 | 29% | 85722 | 73160 | 12562 | 17% |
| &nbsp;&nbsp;&nbsp;&nbsp;Outside commissions | 75492 | 74420 | 1072 | 1% | 207371 | 195658 | 11713 | 6% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other operating expenses | 18499 | 11086 | 7413 | 67% | 50347 | 32473 | 17874 | 55% |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization expense | 5410 | 3850 | 1560 | 41% | 14840 | 10730 | 4110 | 38% |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of contingent consideration | 447 | 3032 | (2585) | (85)% | (398) | 7355 | (7753) | (105)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation expense | 171 | 151 | 20 | 13% | 484 | 463 | 21 | 5% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 130394 | 116156 | 14238 | 12% | 358366 | 319839 | 38527 | 12% |
| Operating income | 16873 | 13638 | 3235 | 24% | 61585 | 36337 | 25248 | 69% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total other income (expense), net | (119) | 57 | (176) | n/m | (352) | 34133 | (34485) | (101)% |
| Income before income taxes and share of net earnings of equity method investment | $16754 | $13695 | $3059 | 22% | $61233 | $70470 | $(9237) | (13)% |

---

__________

n/m&nbsp;&nbsp;&nbsp;&nbsp;not meaningful

**Commissions and Fees**

UCTS generates (i) commissions for underwriting and placing insurance policies and/or treaties on behalf of its insurance company partners and reinsurance company partners; (ii) policy fee and installment fee revenue for acting in the capacity of an MGA and fulfilling certain administrative functions on behalf of insurance or reinsurance company partners, including delivery of policy documents, processing payments and other administrative functions; (iii) profit-sharing income, generally based on the profitability of the underlying book of business of the policies it generates on behalf of its insurance company partners and reinsurance company partners; (iv) fees from service fee arrangements, which are in place with certain clients for a negotiated fee; and (v) assumed premium earned in the Captive business.

------

UCTS commissions and fees increased $17.2 million for the quarter ended September 30, 2025 compared to the same period of 2024, due primarily to organic growth in core commissions and fees. Total growth in our core commissions and fees of $16.2 million for the quarter was driven by continued outperformance in MSI (accounting for $7.7 million of the increase in core commissions and fees), the introduction of the Captive (accounting for $5.9 million of the increase in core commissions and fees), and building momentum in our Capacity Solutions group (accounting for $3.2 million of the increase in core commissions and fees). Total growth in our core commissions and fees included the Partnership contribution of $4.5 million.

UCTS commissions and fees increased $63.1 million for the year-to-date period ended September 30, 2025 compared to the same period of 2024, due primarily to organic growth in core commissions and fees. Total growth in our core commissions and fees of $59.2 million for the year-to-date period was driven by continued outperformance in MSI (accounting for $38.5 million of the increase in core commissions and fees), the introduction of the Captive (accounting for $15.7 million of the increase in core commissions and fees), and building momentum in our Capacity Solutions group (accounting for $11.1 million of the increase in core commissions and fees). Total growth in our core commissions and fees included the Partnership contribution of $6.2 million, as well as the impact of the divestiture of our Wholesale Business in the first quarter of 2024 of $(5.5) million. In addition, profit sharing and other increased $3.9 million for the year-to-date period. Core commissions and fees growth, excluding revenue related to the Wholesale Business during 2024, was 19%.

**Colleague Compensation and Benefits**

Colleague compensation and benefits expense for UCTS increased $6.8 million for the quarter ended September 30, 2025 compared to the same period of 2024. Partnership activity contributed $2.2 million to the increase in colleague compensation and benefits during the third quarter of 2025. After excluding colleague compensation and benefits expense related to Partnership activity, colleague compensation and benefits increased $4.5 million as a result of the growth in UCTS.

Colleague compensation and benefits expense for UCTS increased $12.6 million for the year-to-date period ended September 30, 2025 compared to the same period of 2024. Partnership activity contributed $3.6 million to the increase in colleague compensation and benefits year-to-date in 2025, offset in part by a $1.4 million decrease related to divestiture activity during 2024. After excluding colleague compensation and benefits expense related to partnership and divestiture activity, colleague compensation and benefits increased $10.3 million as a result of the growth in UCTS.

**Outside Commissions**

Outside commissions for UCTS consist of outside commissions paid to partners that distribute our MGA products. Outside commissions for UCTS increased $1.1 million, or 1%, for the quarter ended September 30, 2025 compared to the same period of 2024. Outside commissions for the quarter increased at a lower rate than core commissions and fees due to continued scaling of the business, product mix shift and contributions from the Capacity Solutions group (which generally does not have significant outside commissions).

Outside commissions for UCTS increased $11.7 million, or 6%, for the year-to-date period ended September 30, 2025 compared to the same period of 2024. After excluding outside commissions of $3.0 million attributable to the Wholesale Business during 2024 for which there was no comparable expense in 2025, outside commissions for UCTS increased $14.7 million, or 8%. Outside commissions for the year-to-date period increased at a lower rate than core commissions and fees due to continued scaling of the business, product mix shift and increased contributions from the Capacity Solutions group (which generally does not have significant outside commissions).

**Other Operating Expenses**

Other operating expenses for UCTS increased $7.4 million for the quarter ended September 30, 2025 compared to the same period of 2024, driven by higher incurred losses and LAE of $5.1 million related to our newly-established Captive business and professional fees of $1.0 million due to increased legal spend.

Other operating expenses for UCTS increased $17.9 million for the year-to-date period ended September 30, 2025 compared to the same period of 2024, driven by higher incurred losses and LAE of $14.0 million related to our newly-established Captive business, professional fees of $2.8 million due to increased legal spend, and licenses and taxes of $1.4 million.

**Amortization Expense**

Amortization expense for UCTS increased $1.6 million and $4.1 million for the quarter and year-to-date periods ended September 30, 2025 compared to the same periods of 2024, respectively, primarily due to an increase in capitalized software, as well as our partnership activity.

------

**Change in Fair Value of Contingent Consideration**

The change in fair value of contingent consideration for UCTS was a $0.4 million loss for the quarter ended September 30, 2025 compared to a $3.0 million loss for the same period of 2024, and a $0.4 million gain for the year-to-date period ended September 30, 2025 compared to a $7.4 million loss for the same period of 2024. The fair value gains and losses for the quarter and year-to-date periods ended September 30, 2025 were impacted by both positive and negative changes in revenue growth trends of its partners.

**Total Other Income (Expense), Net**

Total other income (expense), net for UCTS decreased $34.5 million for the year-to-date period ended September 30, 2025 compared to the same period of 2024, driven by a $35.1 million gain recorded during 2024 in connection with the sale of our Wholesale Business.

**MAINSTREET INSURANCE SOLUTIONS OPERATING GROUP RESULTS**

MIS offers personal insurance, commercial insurance, and life and health solutions to individuals and businesses in their communities, with a focus on accessing clients via sheltered distribution channels, which include, but are not limited to, new home builders, realtors, mortgage originators/lenders, master planned communities, and various other community centers of influence. MIS also offers consultation for government assistance programs and solutions, including traditional Medicare, Medicare Advantage and Affordable Care Act, to seniors and eligible individuals through a network of primarily independent contractor agents.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **For the Three Months<br> Ended September 30,** | **For the Three Months<br> Ended September 30,** | **Variance** | **Variance** | **For the Nine Months<br> Ended September 30,** | **For the Nine Months<br> Ended September 30,** | **Variance** | **Variance** |
| **(in thousands, except percentages)** | **2025** | **2024** | **Amount** | **%** | **2025** | **2024** | **Amount** | **%** |
| Revenues: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Core commissions and fees | $65403 | $61983 | $3420 | 6% | $198362 | $192971 | $5391 | 3% |
| &nbsp;&nbsp;&nbsp;Profit-sharing and other income | 11026 | 8675 | 2351 | 27% | 22386 | 16451 | 5935 | 36% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commissions and fees | 76429 | 70658 | 5771 | 8% | 220748 | 209422 | 11326 | 5% |
| &nbsp;&nbsp;&nbsp;Investment income | 47 |  | 47 | —% | 161 |  | 161 | —% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | 76476 | 70658 | 5818 | 8% | 220909 | 209422 | 11487 | 5% |
| Operating expenses: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Colleague compensation and benefits | 26521 | 23098 | 3423 | 15% | 78395 | 73518 | 4877 | 7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Outside commissions | 18646 | 19274 | (628) | (3)% | 56790 | 58085 | (1295) | (2)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other operating expenses | 9498 | 9123 | 375 | 4% | 28841 | 25765 | 3076 | 12% |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization expense | 10997 | 6368 | 4629 | 73% | 25777 | 18945 | 6832 | 36% |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of contingent consideration |  | 211 | (211) | (100)% | 279 | 212 | 67 | 32% |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation expense | 180 | 190 | (10) | (5)% | 539 | 528 | 11 | 2% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 65842 | 58264 | 7578 | 13% | 190621 | 177053 | 13568 | 8% |
| Operating income | 10634 | 12394 | (1760) | (14)% | 30288 | 32369 | (2081) | (6)% |
| &nbsp;&nbsp;&nbsp;Total other income (expense), net | (172) | 4 | (176) | n/m | (668) | 2 | (670) | n/m |
| Income before income taxes and share of net earnings of equity method investment | $10462 | $12398 | $(1936) | (16)% | $29620 | $32371 | $(2751) | (8)% |

---

__________

n/m&nbsp;&nbsp;&nbsp;&nbsp;not meaningful

------

**Commissions and Fees**

MIS generates (i) commissions for placing insurance policies on behalf of its insurance company partners; (ii) profit-sharing income based on either the underlying book of business or performance, such as loss ratios; and (iii) commissions and fees in the form of marketing income, which is earned through co-branded marketing campaigns with our insurance company partners.

MIS commissions and fees increased $5.8 million for the quarter ended September 30, 2025 compared to the same period of 2024. MIS core commissions and fees increased $3.4 million in total resulting from the recently acquired Hippo's Homebuilder Distribution Network (accounting for $7.4 million of the increase in core commissions and fees), our national mortgage and real estate channel (accounting for $1.0 million of the increase in core commissions and fees) and our legacy Mainstreet business (accounting for $0.7 million of the increase in core commissions and fees). The overall growth was partially offset by lower core commissions and fees from our Medicare business of $2.8 million and our Westwood business of $2.7 million. In addition, MIS profit-sharing and other revenue increased $2.4 million resulting from improvements in loss ratios and the number of policies sold.

MIS commissions and fees increased $11.3 million for the year-to-date period ended September 30, 2025 compared to the same period of 2024. MIS core commissions and fees increased $5.4 million in total resulting from the recently acquired Hippo's Homebuilder Distribution Network (accounting for $7.4 million of the increase in core commissions and fees), our national mortgage and real estate channel (accounting for $1.3 million of the increase in core commissions and fees) and our legacy Mainstreet business (accounting for $1.0 million of the increase in core commissions and fees). The overall growth was partially offset by lower core commissions and fees from our Medicare business of $2.8 million. In addition, MIS profit-sharing and other revenue increased $5.9 million resulting from improvements in loss ratios and the number of policies sold.

Effective May 1, 2025, we are receiving reduced commissions from QBE Insurance Corporation and its affiliates on the portion of our builder-sourced homeowners book of business we are rolling into the Reciprocal; a temporary headwind that is expected to persist through the first half of 2026 before reversing into a tailwind.

**Colleague Compensation and Benefits**

Colleague compensation and benefits expense for MIS increased $3.4 million for the quarter ended September 30, 2025 compared to the same period of 2024. After excluding colleague compensation and benefits expense related to Partnership activity, colleague compensation and benefits increased $2.5 million, which is in line with the prior-year period as percentage of our core commissions and fees.

Colleague compensation and benefits expense for MIS increased $4.9 million for the year-to-date period ended September 30, 2025 compared to the same period of 2024. After excluding colleague compensation and benefits expense related to Partnership activity, colleague compensation and benefits increased $4.0 million, which is in line with the prior-year period as percentage of our core commissions and fees.

**Other Operating Expenses**

Other operating expenses for MIS increased $3.1 million for the year-to-date period ended September 30, 2025 compared to the same period of 2024, driven by higher legal settlement expense of $0.7 million, rent expense of $0.5 million and technology and software-related costs of $0.4 million.

**Amortization Expense**

MIS amortization expense increased $4.6 million and $6.8 million for the quarter and year-to-date periods ended September 30, 2025 compared to the same periods of 2024, respectively, driven by our partnership activity and an increase in capitalized software.

------

**CORPORATE AND OTHER RESULTS**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **For the Three Months<br> Ended September 30,** | **For the Three Months<br> Ended September 30,** | **Variance** | **Variance** | **For the Nine Months<br> Ended September 30,** | **For the Nine Months<br> Ended September 30,** | **Variance** | **Variance** |
| **(in thousands, except percentages)** | **2025** | **2024** | **Amount** | **%** | **2025** | **2024** | **Amount** | **%** |
| Revenues: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Commissions and fees | $(17178) | $(21701) | $4523 | (21)% | $(54230) | $(57770) | $3540 | (6)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment income | 304 | 849 | (545) | (64)% | 1517 | 1507 | 10 | 1% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | (16874) | (20852) | 3978 | (19)% | (52713) | (56263) | 3550 | (6)% |
| Operating expenses: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Colleague compensation and benefits | 12643 | 9215 | 3428 | 37% | 34671 | 27859 | 6812 | 24% |
| &nbsp;&nbsp;&nbsp;&nbsp;Outside commissions | (17178) | (21701) | 4523 | (21)% | (54230) | (57770) | 3540 | (6)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other operating expenses | 8730 | 8532 | 198 | 2% | 29622 | 23632 | 5990 | 25% |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization expense | 671 | 246 | 425 | 173% | 1594 | 572 | 1022 | 179% |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation expense | 985 | 853 | 132 | 15% | 2912 | 2534 | 378 | 15% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 5851 | (2855) | 8706 | n/m | 14569 | (3173) | 17742 | n/m |
| Operating loss | (22725) | (17997) | (4728) | 26% | (67282) | (53090) | (14192) | 27% |
| Other income (expense): |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense, net | (31016) | (31346) | 330 | (1)% | (92060) | (94230) | 2170 | (2)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on divestitures |  |  |  | —% | (1611) |  | (1611) | —% |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on extinguishment and modification of debt | (3290) | (389) | (2901) | 746% | (5684) | (15068) | 9384 | (62)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income (expense), net | (86) | (35) | (51) | 146% | 1446 | (188) | 1634 | n/m |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other expense, net | (34392) | (31770) | (2622) | 8% | (97909) | (109486) | 11577 | (11)% |
| Loss before income taxes and share of net earnings of equity method investment | $(57117) | $(49767) | $(7350) | 15% | $(165191) | $(162576) | $(2615) | 2% |

---

__________

n/m&nbsp;&nbsp;&nbsp;&nbsp;not meaningful

**Commissions and Fees**

Corporate and Other records the elimination of intercompany commission revenue from the operating groups. During the quarter and year-to-date periods ended September 30, 2025, IAS recorded commission revenue shared with other operating groups of $0.1 million and $0.3 million, respectively, and UCTS recorded commission revenue shared with other operating groups of $17.1 million and $54.0 million, respectively.

**Colleague Compensation and Benefits**

Colleague compensation and benefits expense in Corporate and Other increased $3.4 million and $6.8 million for the quarter and year-to-date periods ended September 30, 2025 compared to the same periods of 2024, respectively, driven by increases in colleague compensation resulting from our continued growth.

**Outside Commissions**

Outside commissions for Corporate and Other results from the elimination of intercompany commission expense from the operating groups.

**Other Operating Expenses**

Other operating expenses in Corporate and Other increased $6.0 million for the year-to-date period ended September 30, 2025 compared to the same period of 2024, due primarily to higher technology and software-related costs of $2.7 million, professional fees of $1.0 million due to increased legal spend, and travel and entertainment of $0.8 million.

------

**Interest Expense, Net**

Interest expense, net, in Corporate and Other was relatively flat for the quarter ended September 30, 2025 compared to the same period of 2024 resulting from a lower average interest rate due to the 2025 Refinancings, offset by higher average borrowings.

Interest expense, net, in Corporate and Other decreased $2.2 million year-to-date period ended September 30, 2025 compared to the same period of 2024 resulting from a lower average interest rate due to the 2025 Refinancings, offset in part by higher average borrowings. We expect interest expense to remain relatively flat in the near term on a year-over-year basis due to higher borrowings under our Revolving Facility to fund the settlement of deferred payment obligations and certain partnership opportunities, offset by lower expected average interest rates.

**Loss on Extinguishment and Modification of Debt**

Loss on extinguishment and modification of debt in Corporate and Other of $3.3 million for the quarter ended September 30, 2025 relates to the September 2025 Refinancing.

Loss on extinguishment and modification of debt in Corporate and Other of $5.7 million for the year-to-date period ended September 30, 2025 relates to the 2025 Refinancings. Loss on extinguishment and modification of debt of $15.1 million for the year-to-date period ended September 30, 2024 relates to a debt refinancing completed in May 2024.

**LIQUIDITY AND CAPITAL RESOURCES**

Our primary liquidity needs for the foreseeable future will include cash to (i) provide capital to facilitate the organic growth of our business and to fund future partnerships, (ii) pay operating expenses, including cash compensation to our colleagues and expenses related to being a public company, (iii) make payments under the Tax Receivable Agreement, (iv) pay interest and principal due on borrowings under the 2024 Credit Facility and the Senior Secured Notes, (v) pay contingent earnout liabilities, (vi) pay income taxes, and (vii) fund potential investments in third party businesses that support the growth of our business, which may include sponsorship of, and a minority, non-controlling interest in, other investment funds, the purpose of which may include facilitating the establishment of additional and alternative capacity that supports the growth of our MSI business.

We have historically financed our operations and funded our debt service through the sale of our insurance products and services, and we have financed significant cash needs to fund growth through the acquisition of partners through debt and equity financing.

As of September 30, 2025, the 2024 Credit Facility provides for senior secured credit facilities in an aggregate principal amount of $1.61 billion, which consists of (i) a term loan facility in the principal amount of $1.006 billion, bearing interest at a rate of term SOFR, plus an applicable margin of 250 bps, maturing May 24, 2031 (the "2025 Term Loan Facility") and (ii) a revolving credit facility with commitments in an aggregate principal amount of $600 million, bearing interest at SOFR plus 185 bps to SOFR plus 260 bps based on total net leverage ratio, maturing May 24, 2029 (the "Revolving Facility"). As of September 30, 2025, we had $66.0 million outstanding under our Revolving Facility and $10.0 million of undrawn letters of credit issued thereunder.

As of September 30, 2025, Baldwin Holdings also had outstanding $600 million aggregate principal amount of 7.125% senior secured notes due May 15, 2031 (the "Senior Secured Notes"). Refer to Note 10 to our consolidated financial statements included in Part I, Item 1. Financial Statements of this report for more information relating to the terms of the Senior Secured Notes and 2024 Credit Facility.

During September 2025, we entered into a floating-to-fixed interest rate swap agreement with a notional amount of $500.0 million, which exchanges the variable rate of the Term Loans, which are indexed to 1-month term SOFR, for a fixed rate of 3.244%. Interest payments will be made on a monthly basis commencing on October 14, 2025 through the termination date of September 14, 2028. The objective of the swap, for which we elected hedge accounting, is to manage our exposure to interest rate risk by converting a portion of the floating rate cash flows of the Term Loans into fixed rate payments.

In the near term, we intend to fund our earnout obligations with cash and cash equivalents, including unused proceeds from the issuance of the Senior Secured Notes and the 2025 Term Loans, cash flow from operations and available borrowings under the Revolving Facility. From time to time, we will consider raising additional debt or equity financing if and as necessary to support our growth, including in connection with the exploration of partnership opportunities or to refinance existing obligations on an opportunistic basis.

------

In addition, we continue to evaluate our capital structure and current market conditions related to our capital structure. In addition to exploring partnership or refinancing opportunities, we may consider, if authorized by our Board of Directors, the repurchase of our common stock in open market or privately negotiated transactions. We have broad discretion over the deployment of our capital and these initiatives may not be successful or could limit our liquidity otherwise available.

As of September 30, 2025, our cash and cash equivalents were $89.7 million and we had $524 million of available borrowing capacity on the Revolving Facility. We believe that our cash and cash equivalents, cash flow from operations and available borrowings will be sufficient to fund our working capital and meet our commitments for the next twelve months and beyond.

**Contractual Obligations and Commitments**

The following table represents our contractual obligations and commitments, aggregated by type, at September 30, 2025:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Payments Due by Period** | **Payments Due by Period** | **Payments Due by Period** | **Payments Due by Period** |
| **(in thousands)** |<br>**Total** | **Less than<br>1 year** | **1-3 years** | **3-5 years** | **More than<br>5 years** |
| Operating leases<sup>(1)</sup> | $89534 | $21404 | $37813 | $24645 | $5672 |
| Debt obligations payable<sup>(2)</sup> | 2309210 | 124217 | 245321 | 302596 | 1637076 |
| Undiscounted estimated contingent earnout obligation<sup>(3)</sup> | 33592 | 17722 | 11802 | 1987 | 2081 |
| USF Grant | 3352 | 856 | 1696 | 800 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $2435688 | $164199 | $296632 | $330028 | $1644829 |

---

__________

(1)&nbsp;&nbsp;&nbsp;&nbsp;Represents noncancelable operating leases for our facilities. Operating lease expense was $15.8 million and $16.2 million for the nine months ended September 30, 2025 and 2024, respectively.

(2)&nbsp;&nbsp;&nbsp;&nbsp;Represents scheduled debt obligations and estimated interest payments for our Senior Secured Notes, 2025 Term Loans and the Revolving Facility.

(3)&nbsp;&nbsp;&nbsp;&nbsp;Represents the total expected future payments to be made to partners and colleagues for earnout-related obligations at September 30, 2025.

Our contractual obligations and commitments are comprised of operating lease obligations, principal and interest payments on our borrowings under the Senior Secured Notes, the 2025 Term Loans and the Revolving Facility, estimated payments of contingent earnout liabilities, and our commitment to the University of South Florida ("USF").

Our operating lease obligations represent noncancelable agreements for our corporate headquarters and office space for our insurance brokerage business. Our operating lease agreements expire through August 2035. These obligations do not include leases with an initial term of twelve months or less, which are expensed as incurred. We may extend, terminate or otherwise modify or sub-lease facilities as needed to best suit the needs of our business. The lease term is the non-cancelable period of the lease and includes options to extend or terminate the lease when it is reasonably certain that an option will be exercised.

Our debt obligations at September 30, 2025 include borrowings outstanding under the Senior Secured Notes of $600 million, the 2025 Term Loans of $1.004 billion, and the Revolving Facility of $66.0 million. Estimated interest payments for outstanding borrowings under the Senior Secured Notes, 2025 Term Loans, and Revolving Facility in the table above were calculated based on the applicable interest rates at September 30, 2025 of 7.125%, 6.64% and 6.82%, respectively, through their respective due dates of May 15, 2031, May 24, 2031 and May 24, 2029.

------

Substantially all of our partnerships and certain acquisitions of select books of business that do not constitute a complete business enterprise include contractual earnout provisions. We record an estimation of the fair value of the contingent earnout obligations at the partnership date as a component of the consideration paid. Our contingent earnout obligations are measured at fair value each reporting period based on the present value of the expected future payments to be made to partners in accordance with the provisions outlined in the respective purchase agreements. The recorded obligations are based on estimates of the partners' future performance using financial projections for the earnout period. The aggregate estimated contingent earnout liabilities included on our condensed consolidated balance sheet of $28.4 million at September 30, 2025 includes $10.0 million that must be settled in cash and the remaining $18.4 million can be settled in cash or stock at our option. The undiscounted estimated contingent earnout obligation presented in the table above represents the total expected future payments to be made to the partners. The undiscounted estimated contingent earnout obligation of $33.6 million at September 30, 2025 includes $10.0 million that must be settled in cash and the remaining $23.6 million can be settled in cash or stock at our option can be settled in cash or stock at our option. The maximum estimated exposure to the contingent earnout liabilities was $65.5 million at September 30, 2025.

As of September 30, 2025, we have a remaining commitment to USF to donate $3.4 million through October 2028. The gift will provide support for the School of Risk Management and Insurance in the USF Muma College of Business. It is currently anticipated that Lowry Baldwin, our Chairman, will fund half of this commitment.

**Tax Receivable Agreement**

We expect to obtain an increase in our share of the tax basis in the assets of Baldwin Holdings when its LLC Units are redeemed or exchanged for shares of Baldwin's Class A common stock. This increase in tax basis may have the effect of reducing the future amounts paid to various tax authorities. The increase in tax basis may also decrease gains (or increase losses) on future dispositions of certain capital assets to the extent tax basis is allocated to those capital assets.

We have a Tax Receivable Agreement that provides for the payment by us to the parties to the Tax Receivable Agreement of 85% of the amount of cash savings, if any, in U.S. federal, state and local income tax or franchise tax that we actually realize as a result of (i) any increase in tax basis in Baldwin's assets and (ii) tax benefits related to imputed interest deemed arising as a result of payments made under the Tax Receivable Agreement.

During the nine months ended September 30, 2025, we redeemed 2,383,868 LLC Units of Baldwin Holdings on a one-for-one basis for shares of Class A common stock and cancelled the corresponding shares of Class B common stock. We receive an increase in our share of the tax basis in the net assets of Baldwin Holdings due to the interests being redeemed. We have assessed the realizability of the net deferred tax assets and in that analysis have considered the relevant positive and negative evidence available to determine whether it is more likely than not that some portion or all of the deferred tax assets will be realized. We have recorded a full valuation allowance against the deferred tax assets at Baldwin as of September 30, 2025, which will be maintained until there is sufficient evidence to support the reversal of all or some portion of these allowances.

As of September 30, 2025 and December 31, 2024, we have recorded a Tax Receivable Agreement liability of $5.2 million and $4.8 million, respectively, associated with the payments to be made to current or former Baldwin Holdings' LLC Members subject to the Tax Receivable Agreement.

**Sources and Uses of Cash** 

The following table summarizes our cash flows from operating, investing and financing activities for the periods indicated:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Nine Months<br> Ended September 30,** | **For the Nine Months<br> Ended September 30,** | |
| **(in thousands)** | **2025** | **2024** | **Variance** |
| Net cash provided by (used in) operating activities | $(39687) | $53754 | $(93441) |
| Net cash provided by (used in) investing activities | (129577) | 25609 | (155186) |
| Net cash provided by financing activities | 182439 | 38390 | 144049 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net increase in cash and cash equivalents and fiduciary cash | 13175 | 117753 | (104578) |
| Cash and cash equivalents and fiduciary cash at beginning of period | 312769 | 226963 | 85806 |
| Cash and cash equivalents and fiduciary cash at end of period | $325944 | $344716 | $(18772) |

---

------

***Operating Activities***

The primary sources and uses of cash for operating activities are net income (loss) adjusted for non-cash items and changes in assets and liabilities, or operating working capital, and payment of contingent earnout consideration. Net cash used in operating activities increased $93.4 million year over year, primarily as a result of a $63.9 million increase in payments of contingent earnout consideration in excess of purchase price accrual.

***Investing Activities***

The primary sources and uses of cash for investing activities relate to cash consideration paid to fund partnerships, proceeds from divested assets, and other investments to grow our business. Net cash used in investing activities increased $155.2 million year over year driven by a decrease in cash proceeds from divestitures, net of cash transferred of $55.1 million relating primarily to the sale of our Wholesale Business during 2024, an increase in investments in and loans for business ventures of $14.1 million related to our investment in the Reciprocal in 2025, and an increase in cash consideration paid for partnership activity of $85.7 million.

***Financing Activities***

The primary sources and uses of cash for financing activities relate to the issuance of our Class A common stock; debt servicing costs in connection with our long-term debt and revolving line of credit, as well as purchases, sales and settlements of interest rate caps to mitigate interest rate volatility on that debt; payment of contingent earnout consideration; and other equity transactions. Net cash provided by financing activities increased $144.0 million year over year driven by an increase in net proceeds from borrowings on our credit facilities of $153.5 million primarily resulting from the 2025 Refinancings and borrowings on the Revolving Facility to fund partnerships and the payment of our earnout obligations during 2025. This increase was partially offset by a decrease in cash of $18.5 million related to the change in fiduciary receivables and liabilities.

**CRITICAL ACCOUNTING ESTIMATES**

Our consolidated financial statements are prepared in accordance with GAAP, which requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Our estimates, judgments and assumptions are continually evaluated based on historical experience, known or expected trends, independent valuations and other factors we believe to be reasonable under the circumstances. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates.

During the nine months ended September 30, 2025, we amended our critical accounting estimates to include the valuation of acquired relationships, the determination of which could have a significant impact on our results of operations.

Valuation of Acquired Relationships—We acquire significant intangible assets in connection with our strategic acquisitions of a business and, typically, acquired relationships are the most significant definite-lived intangible asset acquired. We engage a third-party valuation expert to determine the fair value of these assets, which generally involves the use of a discounted cash flow approach that is derived from historical information, future revenue and operating profit margins, contributory asset charges, and the selection of an appropriate discount rate, and requires management to make significant estimates and assumptions.

The Company's critical accounting policies and estimates are described under Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations of our Annual Report on Form 10-K for the year ended December 31, 2024. With the exception of the addition of the valuation of acquired relationships as discussed above, there have been no material changes to the critical accounting policies and estimates disclosed in out Annual Report on Form 10-K for the year ended December 31, 2024.

**RECENT ACCOUNTING PRONOUNCEMENTS**

Please refer to Note 1 to our condensed consolidated financial statements included in Part I, Item 1. Financial Statements of this report for a discussion of recent accounting pronouncements that may impact us.

------

**ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

Market risk is the potential loss arising from adverse changes in market rates and prices, such as premium amounts, interest rates and equity prices. We are exposed to market risk through our investments and borrowings under the 2024 Credit Facility. We use derivative instruments to mitigate our risk related to the effect of rising interest rates on our cash flows. However, we do not use derivative instruments for trading or speculative purposes.

Our invested assets are held primarily as cash and cash equivalents and restricted cash. To a lesser extent, we may also utilize certificates of deposit, U.S. treasury securities and professionally managed short duration fixed income funds. These investments are subject to market risk. The fair value of our invested assets at September 30, 2025 and December 31, 2024 approximated their respective carrying values due to their short-term duration and therefore, such market risk is not considered to be material.

During September 2025, the 2024 Credit Agreement was amended to, among other things, (i) reprice the Existing 2025 Term Loans with interest at term SOFR, plus an applicable margin of 250 bps; (ii) provide for $75.0 million of incremental term B loans; and (iii) reduce the applicable margin for the Revolving Facility to term SOFR, plus a credit spread adjustment of 10 bps, plus an applicable margin of 175 bps to 250 bps based on total net leverage ratio.

Also during September 2025, we entered into a floating-to-fixed interest rate swap agreement with a notional amount of $500.0 million, which exchanges the variable rate of the Term Loans, which are indexed to 1-month term SOFR, for a fixed rate of 3.244%. The objective of the swap, for which we elected hedge accounting, is to manage our exposure to interest rate risk by converting a portion of the floating rate cash flows of the Term Loans into fixed rate payments. This strategy provides predictability in interest expense and aligns with our risk management policy.

At September 30, 2025, we had outstanding borrowings of $1.004 billion under the Term Loans and $66.0 million under our Revolving Facility. Taking the interest rate swap into consideration, an increase of 100 basis points on the SOFR rate at September 30, 2025 would have increased our annual interest expense under the 2024 Credit Facility by $5.7 million.

Other than the amendments to the 2024 Credit Agreement to increase the aggregate principal amount of the 2025 Term Loans to $1.006 billion and the interest rate swap agreement, there have been no material changes in market risk from the information presented in Part II, Item 7A. Quantitative and Qualitative Disclosures About Market Risk in our Annual Report on Form 10-K for the year ended December 31, 2024.

**ITEM 4. CONTROLS AND PROCEDURES**

**Evaluation of Disclosure Controls and Procedures**

Under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of September 30, 2025 to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms and that such information is accumulated and communicated to our senior management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosures.

**Changes in Internal Control over Financial Reporting**

There were no changes in our internal control over financial reporting that occurred during the quarter ended September 30, 2025, which were identified in connection with management's evaluation required by paragraph (d) of Rules 13a-15 and 15d-15 under the Exchange Act, that materially affected, or that are reasonably likely to materially affect, our internal control over financial reporting.

------

**PART II. OTHER INFORMATION**

**ITEM 1. LEGAL PROCEEDINGS**

Please refer to Note 16 to our condensed consolidated financial statements included in Part I, Item 1. Financial Statements of this report for a discussion of legal proceedings to which the Company is subject.

**ITEM 1A. RISK FACTORS**

Please refer to the risk factors outlined under Part I, Item 1A. Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on February 25, 2025.

**ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS**

**Sales of Unregistered Securities**

The following list sets forth information regarding all unregistered securities sold or issued by us during the current year. No underwriters were involved in these sales. There was no general solicitation of investors or advertising, and we did not pay or give, directly or indirectly, any commission or other remuneration, in connection with the offering of these securities. In the transactions described below, the recipients of the securities represented their intention to acquire the securities for investment only and not with a view to or for sale in connection with any distribution thereof, and appropriate legends were affixed to the securities issued in these transactions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• On April 1, 2025, as partial consideration for the acquisition of certain assets and equity interests of entities used in the operation of Bermuda-based reinsurance underwriting platform MultiStrat Group, Baldwin issued 23,202 shares of Class A common stock.

The securities described above were issued to a limited number of investors, all of which had sufficient knowledge and experience in financial and business matters to make them capable of evaluating the merits and risks of the prospective investment, and for nominal consideration. The offer, sale and issuance of the securities described above were deemed to be exempt from registration under the Securities Act in reliance upon Section 4(a)(2) of the Securities Act as transactions by an issuer not involving any public offering.

**Issuer Repurchases of Equity Securities**

The following table provides information about our repurchase of shares of our Class A common stock during the three months ended September 30, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Total Number of Shares Purchased**<sup>(1)</sup> | **Average Price Paid per Share** | **Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs** | **Maximum Value that may yet be Purchased under the Plans or Programs** |
| July 1, 2025 to July 31, 2025 | 32218 | $41.60 |  | $— |
| August 1, 2025 to August 31, 2025 | 19223 | 35.29 |  |  |
| September 1, 2025 to September 30, 2025 | 3209 | 31.85 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 54650 | $38.81 |  | $— |

---

__________

(1)&nbsp;&nbsp;&nbsp;&nbsp;We purchased 54,650 shares during the three months ended September 30, 2025, which were acquired from our employees to cover required tax withholding on the vesting of shares granted under our Omnibus Incentive Plan or Partnership Inducement Award Plan.

**ITEM 3. DEFAULTS UPON SENIOR SECURITIES**

None.

**ITEM 4. MINE SAFETY DISCLOSURES**

Not applicable.

------

**ITEM 5. OTHER INFORMATION**

**Insider Trading Arrangements and Policies**

During the quarter ended September 30, 2025, none of our directors or officers adopted, modified or terminated any contract, instruction or written plan for the purchase or sale of our securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K).

**ITEM 6. EXHIBITS**

The following exhibits are filed as a part of this Quarterly Report on Form 10-Q:

---

| | |
|:---|:---|
| **Exhibit No.** | **Description of Exhibit** |
| 3.1 | <u>[Amended and Restated Certificate of Incorporation of the Company (incorporated herein by reference to Exhibit 3.1 of the registrant's Current Report on Form 8-K filed with the Securities and Exchange Commission on October 31, 2019).](https://www.sec.gov/Archives/edgar/data/1781755/000119312519280565/d826170dex31.htm)</u> |
| 3.2 | <u>[Certificate of Amendment to the Company's Amended and Restated Certificate of Incorporation (incorporated herein by reference to Exhibit 3.1 of the registrant's Current Report on Form 8-K filed with the Securities and Exchange Commission on October 15, 2020).](https://www.sec.gov/Archives/edgar/data/1781755/000119312520269464/d942169dex31.htm)</u> |
| 3.3 | <u>[Certificate of Amendment to the Company's Amended and Restated Certificate of Incorporation (incorporated herein by reference to Exhibit 3.3 of the registrant's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 7, 2024).](https://www.sec.gov/Archives/edgar/data/1781755/000178175524000030/exhibit-33fy2024q1.htm)</u> |
| 3.4 | <u>[Second Amended and Restated By-Laws of the Company (incorporated herein by reference to Exhibit 3.4 of the registrant's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 7, 2024).](https://www.sec.gov/Archives/edgar/data/1781755/000178175524000030/exhibit-34fy2024q1.htm)</u> |
| 3.5 | <u>[First Amendment to the Second Amended and Restated By-laws of The Baldwin Insurance Group, Inc. (incorporated herein by reference to Exhibit 3.1 of the registrant's Current Report on Form 8-K filed with the Securities and Exchange Commission on October 31, 2024).](https://www.sec.gov/Archives/edgar/data/1781755/000178175524000086/exhibit31202410308-k.htm)</u> |
| 10.1 | <u>[Amendment No. 3 to Amended and Restated Credit Agreement, dated as of September 18, 2025, by and among Baldwin Holdings, the Guarantors party thereto and JPMorgan Chase Bank, N.A., as administrative agent (incorporated herein by reference to Exhibit 10.1 to the registrant's Current Report on Form 8-K filed with the Securities and Exchange Commission on September 18, 2025).](https://www.sec.gov/Archives/edgar/data/1781755/000119312525207391/d71891dex101.htm)</u> |
| 31.1\* | <u>[Certification of the Registrant's Chief Executive Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934](exhibit-311fy2025q3.htm)</u> |
| 31.2\* | <u>[Certification of the Registrant's Chief Financial Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934](exhibit-312fy2025q3.htm)</u> |
| 32\*\* | <u>[Certification of the Registrant's Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](exhibit-32fy2025q3.htm)</u> |
| 101.INS\* | Inline XBRL Instance Document - the Instance document does not appear in the Interactive Data file because XBRL tags are embedded within the Inline XBRL document |
| 101.SCH\* | Inline XBRL Taxonomy Extension Schema Document |
| 101.CAL\* | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.DEF\* | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB\* | Inline XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE\* | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |

---

**__________**

**\*&nbsp;&nbsp;&nbsp;&nbsp;**Filed herewith

\*\*&nbsp;&nbsp;&nbsp;&nbsp;Furnished herewith and as such are deemed not "filed" for purposes of Section 18 of the Exchange Act, nor shall they be deemed incorporated by reference in any filing under the Securities Act, except as shall be expressly set forth by specific reference in such filing.

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | | **The Baldwin Insurance Group, Inc.** |
| Date: November 4, 2025 | By: | /s/ Trevor L. Baldwin |
|  |  | Trevor L. Baldwin |
|  |  | *Chief Executive Officer* |
| Date: November 4, 2025 | By: | /s/ Bradford L. Hale |
|  |  | Bradford L. Hale |
|  |  | *Chief Financial Officer* |

---

## Exhibit 31.1

Exhibit 31.1

CERTIFICATION BY CHIEF EXECUTIVE OFFICER

PURSUANT TO SECURITIES EXCHANGE ACT RULE 13a-14(a) and 15d-14(a),

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Trevor L. Baldwin, certify that:

1.&nbsp;&nbsp;&nbsp;&nbsp;I have reviewed this Quarterly Report on Form 10-Q of The Baldwin Insurance Group, Inc.;

2.&nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.&nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an Annual Report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| |
|:---|
| /s/ Trevor L. Baldwin |
| Trevor L. Baldwin |
| *Chief Executive Officer* |
| Date: November 4, 2025 |

---

## Exhibit 31.2

Exhibit 31.2

CERTIFICATION BY CHIEF FINANCIAL OFFICER

PURSUANT TO SECURITIES EXCHANGE ACT RULE 13a-14(a) and 15d-14(a),

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Bradford L. Hale, certify that:

1.&nbsp;&nbsp;&nbsp;&nbsp;I have reviewed this Quarterly Report on Form 10-Q of The Baldwin Insurance Group, Inc.;

2.&nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.&nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an Annual Report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| |
|:---|
| /s/ Bradford L. Hale |
| Bradford L. Hale |
| *Chief Financial Officer* |
| Date: November 4, 2025 |

---

## Ex-32

Exhibit 32

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY ACT OF 2002

The certification set forth below is being submitted in connection with The Baldwin Insurance Group, Inc.'s Quarterly Report on Form 10-Q for the quarter ended September 30, 2025 (the "Report") for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and Section 1350 of Chapter 63 of Title 18 of the United States Code.

Trevor L. Baldwin, Chief Executive Officer, and Bradford L. Hale, Chief Financial Officer, of The Baldwin Insurance Group, Inc. (the "Company"), each certify to the best of such officer's knowledge, that:

1.&nbsp;&nbsp;&nbsp;&nbsp;The Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and

2.&nbsp;&nbsp;&nbsp;&nbsp;The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: November 4, 2025 | By: | /s/ Trevor L. Baldwin |
|  |  | Trevor L. Baldwin |
|  |  | *Chief Executive Officer* |
| Date: November 4, 2025 | By: | /s/ Bradford L. Hale |
|  |  | Bradford L. Hale |
|  |  | *Chief Financial Officer* |

---

<br>